| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.606 | 0.006 | 0.606 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.27 0.256 CHEMBL3526639 0.477 0.045 CHEMBL3527500 0.499 0.034 CHEMBL3527579 0.477 0.045 CHEMBL3527578 0.27 0.256 CHEMBL3526638 | ||
| 0.608 | 0.016 | 0.608 | Angiogenesis inhibitor | 0.534 0.024 CHEMBL3526639 0.467 0.036 CHEMBL3527500 0.51 0.028 CHEMBL3527579 0.467 0.036 CHEMBL3527578 0.534 0.024 CHEMBL3526638 0.47 0.035 CHEMBL3526428 0.478 0.034 CHEMBL3527115 0.47 0.035 CHEMBL3526429 | ||
| 0.533 | 0.007 | 0.533 | Vascular endothelial growth factor 2 antagonist | 0.277 0.023 CHEMBL3527500 0.39 0.013 CHEMBL3527579 0.277 0.023 CHEMBL3527578 | ||
| 0.532 | 0.007 | 0.532 | Vascular endothelial growth factor antagonist | 0.285 0.024 CHEMBL3527500 0.39 0.014 CHEMBL3527579 0.285 0.024 CHEMBL3527578 | ||
| 0.541 | 0.026 | 0.683 | Cholesterol antagonist | 0.421 0.045 CHEMBL3526639 0.458 0.039 CHEMBL3527500 0.436 0.043 CHEMBL3527579 0.458 0.039 CHEMBL3527578 0.421 0.045 CHEMBL3526638 0.683 0.009 CHEMBL3526428 0.674 0.01 CHEMBL3527115 0.683 0.009 CHEMBL3526429 | CHEMBL3526429 | |
| 0.503 | 0.009 | 0.665 | Peroxidase inhibitor | 0.632 0.004 CHEMBL3527500 0.665 0.003 CHEMBL3527579 0.632 0.004 CHEMBL3527578 | CHEMBL3527579 | |
| 0.493 | 0.005 | 0.493 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.402 0.014 CHEMBL3527500 0.399 0.014 CHEMBL3527579 0.402 0.014 CHEMBL3527578 | ||
| 0.489 | 0.005 | 0.489 | Protein kinase (CK1) gamma 1 inhibitor | 0.279 0.023 CHEMBL3527500 0.304 0.019 CHEMBL3527579 0.279 0.023 CHEMBL3527578 | ||
| 0.498 | 0.026 | 0.498 | GABA C receptor rho-3 antagonist | 0.4 0.062 CHEMBL3527500 0.387 0.067 CHEMBL3527579 0.4 0.062 CHEMBL3527578 | ||
| 0.491 | 0.025 | 0.491 | Aryl hydrocarbon receptor agonist | 0.412 0.035 CHEMBL3527500 0.356 0.046 CHEMBL3527579 0.412 0.035 CHEMBL3527578 | ||
| 0.493 | 0.034 | 0.55 | 5 Hydroxytryptamine release inhibitor | 0.268 0.203 CHEMBL3526639 0.399 0.079 CHEMBL3527500 0.439 0.057 CHEMBL3527579 0.399 0.079 CHEMBL3527578 0.268 0.203 CHEMBL3526638 0.51 0.029 CHEMBL3526428 0.55 0.019 CHEMBL3527115 0.51 0.029 CHEMBL3526429 | CHEMBL3527115 | |
| 0.448 | 0.011 | 0.448 | EphB2 antagonist | 0.291 0.038 CHEMBL3527500 0.358 0.023 CHEMBL3527579 0.291 0.038 CHEMBL3527578 | ||
| 0.439 | 0.008 | 0.439 | Vascular endothelial growth factor 3 antagonist | 0.296 0.019 CHEMBL3527500 0.269 0.024 CHEMBL3527579 0.296 0.019 CHEMBL3527578 | ||
| 0.442 | 0.011 | 0.442 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.269 0.045 CHEMBL3527500 0.307 0.034 CHEMBL3527579 0.269 0.045 CHEMBL3527578 | ||
| 0.431 | 0.005 | 0.431 | Protein kinase (CK1) gamma inhibitor | 0.253 0.029 CHEMBL3527500 0.259 0.027 CHEMBL3527579 0.253 0.029 CHEMBL3527578 | ||
| 0.407 | 0.01 | 0.407 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.256 0.042 CHEMBL3527500 0.292 0.029 CHEMBL3527579 0.256 0.042 CHEMBL3527578 | ||
| 0.402 | 0.005 | 0.402 | TIE antagonist | 0.216 0.013 CHEMBL3527500 0.201 0.015 CHEMBL3527579 0.216 0.013 CHEMBL3527578 | ||
| 0.385 | 0.005 | 0.385 | TIE-2 antagonist | 0.2 0.014 CHEMBL3527500 0.19 0.016 CHEMBL3527579 0.2 0.014 CHEMBL3527578 | ||
| 0.391 | 0.012 | 0.391 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.271 0.041 CHEMBL3527500 0.272 0.041 CHEMBL3527579 0.271 0.041 CHEMBL3527578 | ||
| 0.396 | 0.018 | 0.396 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.202 0.063 CHEMBL3527500 0.239 0.048 CHEMBL3527579 0.202 0.063 CHEMBL3527578 | ||
| 0.381 | 0.007 | 0.381 | Protein kinase (CK1) gamma 3 inhibitor | 0.238 0.031 CHEMBL3527500 0.259 0.025 CHEMBL3527579 0.238 0.031 CHEMBL3527578 | ||
| 0.366 | 0.007 | 0.393 | M18 aspartyl aminopeptidase inhibitor | 0.393 0.005 CHEMBL3527500 0.36 0.007 CHEMBL3527579 0.393 0.005 CHEMBL3527578 0.101 0.09 CHEMBL3527115 | CHEMBL3527578 | |
| 0.368 | 0.018 | 0.368 | CDC-like kinase 2 inhibitor | 0.186 0.074 CHEMBL3527500 0.263 0.041 CHEMBL3527579 0.186 0.074 CHEMBL3527578 | ||
| 0.354 | 0.005 | 0.354 | Protein kinase (CK1) gamma 2 inhibitor | 0.226 0.025 CHEMBL3527500 0.234 0.024 CHEMBL3527579 0.226 0.025 CHEMBL3527578 | ||
| 0.355 | 0.009 | 0.355 | Gastrin inhibitor | 0.279 0.049 CHEMBL3527500 0.303 0.031 CHEMBL3527579 0.279 0.049 CHEMBL3527578 0.238 0.094 CHEMBL3526428 0.266 0.062 CHEMBL3527115 0.238 0.094 CHEMBL3526429 | ||
| 0.363 | 0.018 | 0.363 | MAP kinase kinase 2 inhibitor | 0.313 0.031 CHEMBL3527500 0.324 0.027 CHEMBL3527579 0.313 0.031 CHEMBL3527578 | ||
| 0.347 | 0.007 | 0.347 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.203 0.018 CHEMBL3527500 0.339 0.007 CHEMBL3527579 0.203 0.018 CHEMBL3527578 | ||
| 0.339 | 0.005 | 0.339 | Vanilloid 1 antagonist | 0.149 0.015 CHEMBL3527500 0.145 0.015 CHEMBL3527579 0.149 0.015 CHEMBL3527578 | ||
| 0.336 | 0.007 | 0.336 | Ephrin antagonist | 0.226 0.018 CHEMBL3527500 0.32 0.008 CHEMBL3527579 0.226 0.018 CHEMBL3527578 | ||
| 0.345 | 0.017 | 0.345 | TRKC antagonist | 0.19 0.073 CHEMBL3527500 0.22 0.059 CHEMBL3527579 0.19 0.073 CHEMBL3527578 | ||
| 0.335 | 0.009 | 0.335 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.147 0.034 CHEMBL3527500 0.161 0.03 CHEMBL3527579 0.147 0.034 CHEMBL3527578 | ||
| 0.33 | 0.006 | 0.33 | Raf kinase inhibitor | 0.177 0.015 CHEMBL3527500 0.33 0.006 CHEMBL3527579 0.177 0.015 CHEMBL3527578 | ||
| 0.326 | 0.004 | 0.453 | Interleukin 8 antagonist | 0.453 0.003 CHEMBL3527500 0.374 0.004 CHEMBL3527579 0.453 0.003 CHEMBL3527578 0.181 0.019 CHEMBL3526428 0.201 0.012 CHEMBL3527115 0.181 0.019 CHEMBL3526429 | CHEMBL3527578 | |
| 0.337 | 0.018 | 0.337 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.174 0.063 CHEMBL3527500 0.22 0.044 CHEMBL3527579 0.174 0.063 CHEMBL3527578 | ||
| 0.32 | 0.003 | 0.32 | 5 Hydroxytryptamine 3A agonist | 0.246 0.005 CHEMBL3527500 0.24 0.006 CHEMBL3527579 0.246 0.005 CHEMBL3527578 | ||
| 0.321 | 0.006 | 0.321 | Chemokine receptor antagonist | 0.267 0.01 CHEMBL3527500 0.159 0.029 CHEMBL3527579 0.267 0.01 CHEMBL3527578 | ||
| 0.325 | 0.016 | 0.424 | Phospholipase C inhibitor | 0.195 0.047 CHEMBL3526639 0.424 0.009 CHEMBL3527500 0.364 0.013 CHEMBL3527579 0.424 0.009 CHEMBL3527578 0.195 0.047 CHEMBL3526638 0.243 0.026 CHEMBL3526428 0.348 0.014 CHEMBL3527115 0.243 0.026 CHEMBL3526429 | CHEMBL3527578 | |
| 0.317 | 0.009 | 0.317 | Vascular endothelial growth factor 1 antagonist | 0.162 0.037 CHEMBL3527500 0.235 0.019 CHEMBL3527579 0.162 0.037 CHEMBL3527578 | ||
| 0.38 | 0.072 | 0.38 | Calpain 2 inhibitor | 0.319 0.103 CHEMBL3527500 0.293 0.119 CHEMBL3527579 0.319 0.103 CHEMBL3527578 | ||
| 0.316 | 0.014 | 0.316 | Neuropeptide Y2 antagonist | 0.279 0.032 CHEMBL3527500 0.298 0.019 CHEMBL3527579 0.279 0.032 CHEMBL3527578 | ||
| 0.306 | 0.01 | 0.306 | Polo-like kinase-3 inhibitor | 0.229 0.032 CHEMBL3527500 0.236 0.029 CHEMBL3527579 0.229 0.032 CHEMBL3527578 | ||
| 0.313 | 0.018 | 0.313 | LIM domain kinase 1 inhibitor | 0.308 0.019 CHEMBL3527500 0.262 0.032 CHEMBL3527579 0.308 0.019 CHEMBL3527578 | ||
| 0.301 | 0.007 | 0.301 | Ferrochelatase inhibitor | 0.149 0.038 CHEMBL3527500 0.176 0.029 CHEMBL3527579 0.149 0.038 CHEMBL3527578 | ||
| 0.299 | 0.011 | 0.299 | TRKB antagonist | 0.124 0.068 CHEMBL3527500 0.143 0.052 CHEMBL3527579 0.124 0.068 CHEMBL3527578 | ||
| 0.287 | 0.005 | 0.287 | Raf kinase C inhibitor | 0.23 0.007 CHEMBL3527500 0.27 0.005 CHEMBL3527579 0.23 0.007 CHEMBL3527578 | ||
| 0.285 | 0.004 | 0.285 | EphA2 antagonist | 0.224 0.009 CHEMBL3527500 0.25 0.006 CHEMBL3527579 0.224 0.009 CHEMBL3527578 0.135 0.04 CHEMBL3526428 0.142 0.035 CHEMBL3527115 0.135 0.04 CHEMBL3526429 | ||
| 0.296 | 0.016 | 0.296 | Growth factor agonist | 0.24 0.036 CHEMBL3527500 0.209 0.055 CHEMBL3527579 0.24 0.036 CHEMBL3527578 0.162 0.116 CHEMBL3526428 0.161 0.118 CHEMBL3527115 0.162 0.116 CHEMBL3526429 | ||
| 0.283 | 0.008 | 0.432 | ATPase inhibitor | 0.226 0.021 CHEMBL3526639 0.25 0.014 CHEMBL3527500 0.213 0.028 CHEMBL3527579 0.25 0.014 CHEMBL3527578 0.226 0.021 CHEMBL3526638 0.432 0.003 CHEMBL3526428 0.374 0.004 CHEMBL3527115 0.432 0.003 CHEMBL3526429 | CHEMBL3526429 | |
| 0.36 | 0.085 | 0.36 | MAP kinase kinase 6 inhibitor | 0.266 0.171 CHEMBL3527579 | ||
| 0.285 | 0.014 | 0.285 | NADPH oxidase inhibitor | 0.232 0.025 CHEMBL3527500 0.273 0.016 CHEMBL3527579 0.232 0.025 CHEMBL3527578 0.227 0.027 CHEMBL3526428 0.266 0.018 CHEMBL3527115 0.227 0.027 CHEMBL3526429 | ||
| 0.308 | 0.041 | 0.308 | 5 Hydroxytryptamine uptake stimulant | 0.248 0.083 CHEMBL3527500 0.28 0.057 CHEMBL3527579 0.248 0.083 CHEMBL3527578 | ||
| 0.307 | 0.041 | 0.307 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.167 0.098 CHEMBL3527500 0.216 0.068 CHEMBL3527579 0.167 0.098 CHEMBL3527578 | ||
| 0.296 | 0.032 | 0.296 | 5 Hydroxytryptamine 1E antagonist | 0.282 0.043 CHEMBL3527500 0.271 0.053 CHEMBL3527579 0.282 0.043 CHEMBL3527578 | ||
| 0.278 | 0.015 | 0.284 | Succinate dehydrogenase inhibitor | 0.146 0.12 CHEMBL3526639 0.256 0.02 CHEMBL3527500 0.284 0.014 CHEMBL3527579 0.256 0.02 CHEMBL3527578 0.146 0.12 CHEMBL3526638 0.16 0.095 CHEMBL3527115 | CHEMBL3527579 | |
| 0.282 | 0.021 | 0.282 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.12 0.068 CHEMBL3527579 | ||
| 0.281 | 0.023 | 0.281 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.108 0.095 CHEMBL3527500 0.107 0.096 CHEMBL3527579 0.108 0.095 CHEMBL3527578 | ||
| 0.261 | 0.005 | 0.261 | Epoxide hydrolase inhibitor | 0.166 0.009 CHEMBL3527500 0.17 0.009 CHEMBL3527579 0.166 0.009 CHEMBL3527578 0.077 0.045 CHEMBL3526428 0.098 0.026 CHEMBL3527115 0.077 0.045 CHEMBL3526429 | ||
| 0.287 | 0.035 | 0.287 | CDC-like kinase 4 inhibitor | 0.178 0.08 CHEMBL3527579 | ||
| 0.26 | 0.01 | 0.26 | Platelet activating factor alpha antagonist | 0.186 0.019 CHEMBL3527500 0.167 0.025 CHEMBL3527579 0.186 0.019 CHEMBL3527578 | ||
| 0.261 | 0.014 | 0.369 | Cystathionine beta-synthase inhibitor | 0.113 0.064 CHEMBL3526639 0.267 0.013 CHEMBL3527500 0.369 0.006 CHEMBL3527579 0.267 0.013 CHEMBL3527578 0.113 0.064 CHEMBL3526638 0.233 0.018 CHEMBL3526428 0.323 0.008 CHEMBL3527115 0.233 0.018 CHEMBL3526429 | CHEMBL3527579 | |
| 0.245 | 0.004 | 0.245 | NMDA receptor agonist | 0.207 0.004 CHEMBL3527500 0.165 0.006 CHEMBL3527579 0.207 0.004 CHEMBL3527578 | ||
| 0.273 | 0.039 | 0.273 | RNA-directed DNA polymerase inhibitor | 0.182 0.129 CHEMBL3526639 0.229 0.065 CHEMBL3527500 0.271 0.039 CHEMBL3527579 0.229 0.065 CHEMBL3527578 0.182 0.129 CHEMBL3526638 0.209 0.087 CHEMBL3526428 0.246 0.052 CHEMBL3527115 0.209 0.087 CHEMBL3526429 | ||
| 0.241 | 0.008 | 0.241 | CC chemokine receptor antagonist | 0.126 0.024 CHEMBL3527500 0.103 0.033 CHEMBL3527579 0.126 0.024 CHEMBL3527578 | ||
| 0.334 | 0.107 | 0.479 | Histamine release inhibitor | 0.276 0.137 CHEMBL3526639 0.403 0.074 CHEMBL3527500 0.273 0.139 CHEMBL3527579 0.403 0.074 CHEMBL3527578 0.276 0.137 CHEMBL3526638 0.479 0.037 CHEMBL3526428 0.464 0.044 CHEMBL3527115 0.479 0.037 CHEMBL3526429 | CHEMBL3526429 | |
| 0.237 | 0.01 | 0.237 | Neuropeptide Y1 antagonist | 0.204 0.017 CHEMBL3527500 0.201 0.018 CHEMBL3527579 0.204 0.017 CHEMBL3527578 | ||
| 0.228 | 0.007 | 0.228 | Stem cell growth factor agonist | 0.123 0.029 CHEMBL3527500 0.092 0.052 CHEMBL3527579 0.123 0.029 CHEMBL3527578 | ||
| 0.227 | 0.007 | 0.25 | HIV-1 integrase (Overall Integration) inhibitor | 0.201 0.011 CHEMBL3527500 0.25 0.005 CHEMBL3527579 0.201 0.011 CHEMBL3527578 | CHEMBL3527579 | |
| 0.289 | 0.069 | 0.331 | Aldehyde oxidase inhibitor | 0.249 0.083 CHEMBL3527500 0.331 0.059 CHEMBL3527579 0.249 0.083 CHEMBL3527578 | CHEMBL3527579 | |
| 0.235 | 0.017 | 0.399 | Cell adhesion inhibitor | 0.179 0.031 CHEMBL3526639 0.203 0.024 CHEMBL3527500 0.123 0.063 CHEMBL3527579 0.203 0.024 CHEMBL3527578 0.179 0.031 CHEMBL3526638 0.399 0.005 CHEMBL3526428 0.358 0.007 CHEMBL3527115 0.399 0.005 CHEMBL3526429 | CHEMBL3526429 | |
| 0.221 | 0.004 | 0.593 | Phosphorylase inhibitor | 0.421 0.003 CHEMBL3526639 0.255 0.004 CHEMBL3527500 0.17 0.006 CHEMBL3527579 0.255 0.004 CHEMBL3527578 0.421 0.003 CHEMBL3526638 0.593 0.002 CHEMBL3526428 0.36 0.003 CHEMBL3527115 0.593 0.002 CHEMBL3526429 | CHEMBL3526429 | |
| 0.25 | 0.034 | 0.25 | Protein kinase C nu inhibitor | 0.114 0.1 CHEMBL3527500 0.179 0.056 CHEMBL3527579 0.114 0.1 CHEMBL3527578 | ||
| 0.221 | 0.006 | 0.221 | Electrolyte absorption antagonist | 0.199 0.008 CHEMBL3527500 0.143 0.022 CHEMBL3527579 0.199 0.008 CHEMBL3527578 | ||
| 0.218 | 0.003 | 0.218 | NMDA receptor glycine site agonist | 0.059 0.047 CHEMBL3526639 0.19 0.003 CHEMBL3527500 0.164 0.004 CHEMBL3527579 0.19 0.003 CHEMBL3527578 0.059 0.047 CHEMBL3526638 | ||
| 0.217 | 0.005 | 0.229 | Sphingosine 1-phosphate receptor 2 antagonist | 0.216 0.005 CHEMBL3527500 0.229 0.005 CHEMBL3527579 0.216 0.005 CHEMBL3527578 | CHEMBL3527579 | |
| 0.262 | 0.052 | 0.262 | MAP-kinase-activated kinase 5 inhibitor | 0.183 0.127 CHEMBL3527500 0.187 0.121 CHEMBL3527579 0.183 0.127 CHEMBL3527578 | ||
| 0.221 | 0.011 | 0.359 | Potassium channel (Ca-activated) activator | 0.359 0.004 CHEMBL3527500 0.244 0.008 CHEMBL3527579 0.359 0.004 CHEMBL3527578 0.089 0.065 CHEMBL3526428 0.089 0.065 CHEMBL3526429 | CHEMBL3527578 | |
| 0.24 | 0.032 | 0.24 | Protein-tyrosine kinase Lyn inhibitor | 0.132 0.076 CHEMBL3527500 0.204 0.044 CHEMBL3527579 0.132 0.076 CHEMBL3527578 | ||
| 0.244 | 0.037 | 0.268 | Nitric-oxide synthase stimulant | 0.239 0.041 CHEMBL3527500 0.252 0.031 CHEMBL3527579 0.239 0.041 CHEMBL3527578 0.254 0.03 CHEMBL3526428 0.268 0.022 CHEMBL3527115 0.254 0.03 CHEMBL3526429 | CHEMBL3527115 | |
| 0.221 | 0.023 | 0.221 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.115 0.073 CHEMBL3527500 0.178 0.035 CHEMBL3527579 0.115 0.073 CHEMBL3527578 | ||
| 0.221 | 0.023 | 0.221 | Abl kinase inhibitor | 0.114 0.073 CHEMBL3527500 0.177 0.035 CHEMBL3527579 0.114 0.073 CHEMBL3527578 | ||
| 0.208 | 0.013 | 0.208 | Vanilloid antagonist | 0.129 0.025 CHEMBL3527500 0.145 0.022 CHEMBL3527579 0.129 0.025 CHEMBL3527578 | ||
| 0.219 | 0.025 | 0.219 | Cyclin-dependent kinase 8 inhibitor | 0.168 0.063 CHEMBL3527500 0.206 0.031 CHEMBL3527579 0.168 0.063 CHEMBL3527578 | ||
| 0.202 | 0.009 | 0.261 | Cell adhesion molecule inhibitor | 0.099 0.035 CHEMBL3526639 0.137 0.018 CHEMBL3527500 0.083 0.05 CHEMBL3527579 0.137 0.018 CHEMBL3527578 0.099 0.035 CHEMBL3526638 0.261 0.006 CHEMBL3526428 0.218 0.008 CHEMBL3527115 0.261 0.006 CHEMBL3526429 | CHEMBL3526429 | |
| 0.201 | 0.009 | 0.215 | Potassium channel activator | 0.215 0.007 CHEMBL3527500 0.141 0.023 CHEMBL3527579 0.215 0.007 CHEMBL3527578 | CHEMBL3527578 | |
| 0.254 | 0.064 | 0.416 | DNA synthesis inhibitor | 0.414 0.02 CHEMBL3526639 0.233 0.08 CHEMBL3527500 0.275 0.053 CHEMBL3527579 0.233 0.08 CHEMBL3527578 0.414 0.02 CHEMBL3526638 0.407 0.021 CHEMBL3526428 0.416 0.02 CHEMBL3527115 0.407 0.021 CHEMBL3526429 | CHEMBL3527115 | |
| 0.227 | 0.038 | 0.227 | 3C-like protease (Human coronavirus) inhibitor | 0.159 0.088 CHEMBL3527500 0.159 0.088 CHEMBL3527578 | ||
| 0.208 | 0.02 | 0.208 | MAP kinase 12 inhibitor | 0.107 0.088 CHEMBL3527500 0.115 0.077 CHEMBL3527579 0.107 0.088 CHEMBL3527578 | ||
| 0.219 | 0.031 | 0.219 | Cytokine production inhibitor | 0.134 0.076 CHEMBL3527500 0.15 0.062 CHEMBL3527579 0.134 0.076 CHEMBL3527578 | ||
| 0.199 | 0.012 | 0.199 | MAP kinase 14 inhibitor | 0.097 0.037 CHEMBL3527579 | ||
| 0.276 | 0.089 | 0.364 | Streptokinase A inhibitor | 0.364 0.058 CHEMBL3527500 0.268 0.093 CHEMBL3527579 0.364 0.058 CHEMBL3527578 | CHEMBL3527578 | |
| 0.204 | 0.022 | 0.204 | MAP kinase 3 inhibitor | 0.158 0.057 CHEMBL3527500 0.173 0.04 CHEMBL3527579 0.158 0.057 CHEMBL3527578 | ||
| 0.219 | 0.037 | 0.219 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.232 | 0.051 | 0.235 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.177 0.098 CHEMBL3527500 0.235 0.049 CHEMBL3527579 0.177 0.098 CHEMBL3527578 | CHEMBL3527579 | |
| 0.184 | 0.004 | 0.214 | D-Ala-D-Ala ligase inhibitor | 0.079 0.071 CHEMBL3526639 0.214 0.003 CHEMBL3527500 0.206 0.003 CHEMBL3527579 0.214 0.003 CHEMBL3527578 0.079 0.071 CHEMBL3526638 | CHEMBL3527578 | |
| 0.195 | 0.017 | 0.233 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.153 0.026 CHEMBL3526639 0.16 0.024 CHEMBL3527500 0.113 0.043 CHEMBL3527579 0.16 0.024 CHEMBL3527578 0.153 0.026 CHEMBL3526638 0.233 0.011 CHEMBL3526428 0.168 0.022 CHEMBL3527115 0.233 0.011 CHEMBL3526429 | CHEMBL3526429 | |
| 0.258 | 0.081 | 0.339 | Transcription factor STAT inhibitor | 0.329 0.042 CHEMBL3527500 0.339 0.038 CHEMBL3527579 0.329 0.042 CHEMBL3527578 | CHEMBL3527579 | |
| 0.234 | 0.057 | 0.234 | Anesthetic general | 0.138 0.128 CHEMBL3526639 0.223 0.063 CHEMBL3527500 0.185 0.083 CHEMBL3527579 0.223 0.063 CHEMBL3527578 0.138 0.128 CHEMBL3526638 0.157 0.106 CHEMBL3526428 0.182 0.085 CHEMBL3527115 0.157 0.106 CHEMBL3526429 | ||
| 0.207 | 0.031 | 0.346 | Hexokinase inhibitor | 0.182 0.048 CHEMBL3526639 0.192 0.04 CHEMBL3527500 0.185 0.045 CHEMBL3527579 0.192 0.04 CHEMBL3527578 0.182 0.048 CHEMBL3526638 0.346 0.007 CHEMBL3526428 0.336 0.007 CHEMBL3527115 0.346 0.007 CHEMBL3526429 | CHEMBL3526429 | |
| 0.207 | 0.032 | 0.28 | Alpha-N-acetylglucosaminidase inhibitor | 0.19 0.037 CHEMBL3526639 0.14 0.061 CHEMBL3527500 0.16 0.05 CHEMBL3527579 0.14 0.061 CHEMBL3527578 0.19 0.037 CHEMBL3526638 0.247 0.023 CHEMBL3526428 0.28 0.018 CHEMBL3527115 0.247 0.023 CHEMBL3526429 | CHEMBL3527115 | |
| 0.178 | 0.004 | 0.178 | Kainate receptor antagonist | 0.119 0.006 CHEMBL3527500 0.086 0.009 CHEMBL3527579 0.119 0.006 CHEMBL3527578 | ||
| 0.178 | 0.005 | 0.178 | Cholecystokinin antagonist | 0.048 0.026 CHEMBL3527500 0.06 0.019 CHEMBL3527579 0.048 0.026 CHEMBL3527578 | ||
| 0.235 | 0.061 | 0.235 | Clk dual-specificity kinase inhibitor | 0.152 0.112 CHEMBL3527579 | ||
| 0.234 | 0.061 | 0.244 | ErbB-1 antagonist | 0.244 0.055 CHEMBL3527500 0.204 0.084 CHEMBL3527579 0.244 0.055 CHEMBL3527578 | CHEMBL3527578 | |
| 0.182 | 0.01 | 0.182 | Cannabinoid receptor antagonist | 0.087 0.035 CHEMBL3527500 0.087 0.035 CHEMBL3527578 | ||
| 0.189 | 0.017 | 0.19 | Sphingosine 1-phosphate receptor 5 antagonist | 0.184 0.021 CHEMBL3527500 0.19 0.016 CHEMBL3527579 0.184 0.021 CHEMBL3527578 | CHEMBL3527579 | |
| 0.176 | 0.005 | 0.176 | Cannabinoid CB1 receptor antagonist | 0.091 0.02 CHEMBL3527500 0.055 0.052 CHEMBL3527579 0.091 0.02 CHEMBL3527578 | ||
| 0.175 | 0.005 | 0.175 | CC chemokine 3 receptor antagonist | 0.114 0.008 CHEMBL3527500 0.092 0.011 CHEMBL3527579 0.114 0.008 CHEMBL3527578 | ||
| 0.229 | 0.058 | 0.229 | MAP kinase kinase 3 inhibitor | |||
| 0.269 | 0.098 | 0.367 | 12-Lipoxygenase inhibitor | 0.367 0.05 CHEMBL3527500 0.333 0.063 CHEMBL3527579 0.367 0.05 CHEMBL3527578 | CHEMBL3527578 | |
| 0.182 | 0.013 | 0.214 | Urease inhibitor | 0.187 0.012 CHEMBL3527500 0.214 0.009 CHEMBL3527579 0.187 0.012 CHEMBL3527578 | CHEMBL3527579 | |
| 0.183 | 0.018 | 0.183 | Falcipain 2 inhibitor | 0.095 0.056 CHEMBL3527500 0.087 0.063 CHEMBL3527579 0.095 0.056 CHEMBL3527578 0.135 0.036 CHEMBL3526428 0.13 0.038 CHEMBL3527115 0.135 0.036 CHEMBL3526429 | ||
| 0.184 | 0.019 | 0.184 | Falcipain inhibitor | 0.095 0.058 CHEMBL3527500 0.087 0.065 CHEMBL3527579 0.095 0.058 CHEMBL3527578 0.136 0.037 CHEMBL3526428 0.131 0.039 CHEMBL3527115 0.136 0.037 CHEMBL3526429 | ||
| 0.249 | 0.084 | 0.324 | Transcription factor STAT3 inhibitor | 0.324 0.042 CHEMBL3527500 0.256 0.079 CHEMBL3527579 0.324 0.042 CHEMBL3527578 | CHEMBL3527578 | |
| 0.191 | 0.029 | 0.197 | Epidermal growth factor receptor kinase inhibitor | 0.165 0.039 CHEMBL3527500 0.197 0.027 CHEMBL3527579 0.165 0.039 CHEMBL3527578 | CHEMBL3527579 | |
| 0.182 | 0.023 | 0.182 | MAP kinase kinase kinase inhibitor | 0.099 0.068 CHEMBL3527500 0.115 0.054 CHEMBL3527579 0.099 0.068 CHEMBL3527578 | ||
| 0.169 | 0.012 | 0.203 | Raf kinase B inhibitor | 0.081 0.029 CHEMBL3527500 0.203 0.009 CHEMBL3527579 0.081 0.029 CHEMBL3527578 | CHEMBL3527579 | |
| 0.168 | 0.014 | 0.347 | NADH dehydrogenase inhibitor | 0.213 0.009 CHEMBL3526639 0.14 0.02 CHEMBL3527500 0.172 0.013 CHEMBL3527579 0.14 0.02 CHEMBL3527578 0.213 0.009 CHEMBL3526638 0.264 0.007 CHEMBL3526428 0.347 0.005 CHEMBL3527115 0.264 0.007 CHEMBL3526429 | CHEMBL3527115 | |
| 0.163 | 0.009 | 0.163 | Purinergic P2 antagonist | 0.061 0.047 CHEMBL3527500 0.073 0.037 CHEMBL3527579 0.061 0.047 CHEMBL3527578 | ||
| 0.169 | 0.018 | 0.169 | Neuropeptide Y antagonist | 0.078 0.062 CHEMBL3527500 0.075 0.068 CHEMBL3527579 0.078 0.062 CHEMBL3527578 | ||
| 0.211 | 0.061 | 0.211 | Focal adhesion kinase 2 inhibitor | 0.151 0.129 CHEMBL3527500 0.159 0.116 CHEMBL3527579 0.151 0.129 CHEMBL3527578 | ||
| 0.189 | 0.042 | 0.189 | Catenin beta inhibitor | 0.162 0.08 CHEMBL3526639 0.156 0.093 CHEMBL3527500 0.185 0.046 CHEMBL3527579 0.156 0.093 CHEMBL3527578 0.162 0.08 CHEMBL3526638 | ||
| 0.191 | 0.044 | 0.241 | Glycogen synthase kinase-3 alpha inhibitor | 0.116 0.088 CHEMBL3527500 0.241 0.029 CHEMBL3527579 0.116 0.088 CHEMBL3527578 | CHEMBL3527579 | |
| 0.184 | 0.038 | 0.184 | M17 leucyl aminopeptidase inhibitor | 0.172 0.044 CHEMBL3527500 0.18 0.04 CHEMBL3527579 0.172 0.044 CHEMBL3527578 | ||
| 0.164 | 0.02 | 0.522 | AMP-activated protein kinase stimulant | 0.165 0.019 CHEMBL3526639 0.154 0.026 CHEMBL3527500 0.162 0.021 CHEMBL3527579 0.154 0.026 CHEMBL3527578 0.165 0.019 CHEMBL3526638 0.432 0.004 CHEMBL3526428 0.522 0.003 CHEMBL3527115 0.432 0.004 CHEMBL3526429 | CHEMBL3527115 | |
| 0.231 | 0.088 | 0.231 | Superoxide dismutase inhibitor | 0.188 0.131 CHEMBL3527500 0.202 0.115 CHEMBL3527579 0.188 0.131 CHEMBL3527578 | ||
| 0.148 | 0.005 | 0.148 | Acetyl-CoA transferase inhibitor | 0.098 0.014 CHEMBL3527500 0.082 0.02 CHEMBL3527579 0.098 0.014 CHEMBL3527578 | ||
| 0.145 | 0.004 | 0.145 | Epoxide hydrolase 2 inhibitor | 0.055 0.005 CHEMBL3527500 0.048 0.006 CHEMBL3527579 0.055 0.005 CHEMBL3527578 | ||
| 0.172 | 0.031 | 0.172 | Aurora-C kinase inhibitor | 0.132 0.08 CHEMBL3527500 0.138 0.069 CHEMBL3527579 0.132 0.08 CHEMBL3527578 | ||
| 0.144 | 0.003 | 0.144 | NMDA receptor glycine site antagonist | 0.144 0.003 CHEMBL3527500 0.093 0.004 CHEMBL3527579 0.144 0.003 CHEMBL3527578 | ||
| 0.145 | 0.008 | 0.16 | Purinergic P2X1 antagonist | 0.105 0.015 CHEMBL3526639 0.16 0.006 CHEMBL3527500 0.143 0.008 CHEMBL3527579 0.16 0.006 CHEMBL3527578 0.105 0.015 CHEMBL3526638 0.091 0.019 CHEMBL3526428 0.076 0.028 CHEMBL3527115 0.091 0.019 CHEMBL3526429 | CHEMBL3527578 | |
| 0.161 | 0.025 | 0.161 | Sphingosine 1-phosphate receptor 4 antagonist | 0.109 0.095 CHEMBL3527500 0.135 0.049 CHEMBL3527579 0.109 0.095 CHEMBL3527578 | ||
| 0.138 | 0.003 | 0.138 | Cyclophilin A inhibitor | 0.058 0.005 CHEMBL3527500 0.061 0.005 CHEMBL3527579 0.058 0.005 CHEMBL3527578 0.028 0.026 CHEMBL3526428 0.029 0.025 CHEMBL3527115 0.028 0.026 CHEMBL3526429 | ||
| 0.137 | 0.003 | 0.137 | Potassium channel Kv1.1 blocker | 0.078 0.005 CHEMBL3527500 0.067 0.007 CHEMBL3527579 0.078 0.005 CHEMBL3527578 | ||
| 0.177 | 0.044 | 0.177 | Interleukin 1 antagonist | 0.122 0.086 CHEMBL3527500 0.122 0.086 CHEMBL3527578 | ||
| 0.158 | 0.026 | 0.395 | UDP-glucose 4-epimerase inhibitor | 0.208 0.017 CHEMBL3526639 0.171 0.023 CHEMBL3527500 0.191 0.019 CHEMBL3527579 0.171 0.023 CHEMBL3527578 0.208 0.017 CHEMBL3526638 0.373 0.007 CHEMBL3526428 0.395 0.006 CHEMBL3527115 0.373 0.007 CHEMBL3526429 | CHEMBL3527115 | |
| 0.148 | 0.017 | 0.154 | MAP kinase kinase 1 inhibitor | 0.143 0.019 CHEMBL3527500 0.154 0.015 CHEMBL3527579 0.143 0.019 CHEMBL3527578 | CHEMBL3527579 | |
| 0.146 | 0.016 | 0.146 | Histamine N-methyltransferase inhibitor | 0.097 0.048 CHEMBL3527500 0.094 0.052 CHEMBL3527579 0.097 0.048 CHEMBL3527578 | ||
| 0.203 | 0.073 | 0.203 | Death-associated protein kinase 3 inhibitor | 0.144 0.132 CHEMBL3527500 0.192 0.079 CHEMBL3527579 0.144 0.132 CHEMBL3527578 | ||
| 0.142 | 0.013 | 0.142 | Adenosine A3 receptor antagonist | 0.08 0.043 CHEMBL3526639 0.101 0.026 CHEMBL3527500 0.11 0.022 CHEMBL3527579 0.101 0.026 CHEMBL3527578 0.08 0.043 CHEMBL3526638 | ||
| 0.159 | 0.032 | 0.159 | MAP kinase 13 inhibitor | |||
| 0.145 | 0.021 | 0.145 | Interleukin 2 antagonist | 0.1 0.092 CHEMBL3527500 0.123 0.04 CHEMBL3527579 0.1 0.092 CHEMBL3527578 | ||
| 0.29 | 0.167 | 0.351 | DNA directed DNA polymerase inhibitor | 0.351 0.138 CHEMBL3527500 0.253 0.189 CHEMBL3527579 0.351 0.138 CHEMBL3527578 | CHEMBL3527578 | |
| 0.176 | 0.053 | 0.176 | Cyclin-dependent kinase 3 inhibitor | 0.141 0.12 CHEMBL3527500 0.167 0.064 CHEMBL3527579 0.141 0.12 CHEMBL3527578 | ||
| 0.157 | 0.035 | 0.157 | Interleukin 1b antagonist | 0.113 0.068 CHEMBL3527500 0.113 0.068 CHEMBL3527578 | ||
| 0.133 | 0.012 | 0.136 | GABA aminotransferase inhibitor | 0.108 0.022 CHEMBL3527500 0.122 0.015 CHEMBL3527579 0.108 0.022 CHEMBL3527578 0.097 0.029 CHEMBL3526428 0.136 0.011 CHEMBL3527115 0.097 0.029 CHEMBL3526429 | CHEMBL3527115 | |
| 0.181 | 0.061 | 0.202 | MAP kinase kinase 5 inhibitor | 0.202 0.03 CHEMBL3527579 0.154 0.136 CHEMBL3527115 | CHEMBL3527579 | |
| 0.143 | 0.022 | 0.231 | Triose-phosphate isomerase inhibitor | 0.105 0.043 CHEMBL3526639 0.105 0.043 CHEMBL3527500 0.117 0.034 CHEMBL3527579 0.105 0.043 CHEMBL3527578 0.105 0.043 CHEMBL3526638 0.203 0.01 CHEMBL3526428 0.231 0.008 CHEMBL3527115 0.203 0.01 CHEMBL3526429 | CHEMBL3527115 | |
| 0.124 | 0.004 | 0.124 | Dihydroorotate oxidase inhibitor | 0.104 0.004 CHEMBL3527500 0.103 0.005 CHEMBL3527579 0.104 0.004 CHEMBL3527578 | ||
| 0.127 | 0.007 | 0.127 | 5 Hydroxytryptamine 3 agonist | 0.071 0.035 CHEMBL3527500 0.07 0.036 CHEMBL3527579 0.071 0.035 CHEMBL3527578 | ||
| 0.158 | 0.039 | 0.158 | Pregnane X receptor agonist | 0.124 0.116 CHEMBL3527500 0.124 0.116 CHEMBL3527578 | ||
| 0.176 | 0.058 | 0.248 | Interleukin 6 antagonist | 0.178 0.056 CHEMBL3527579 0.233 0.027 CHEMBL3526428 0.248 0.023 CHEMBL3527115 0.233 0.027 CHEMBL3526429 | CHEMBL3527115 | |
| 0.121 | 0.004 | 0.121 | Potassium channel (Inward rectifier) activator | 0.077 0.009 CHEMBL3527500 0.089 0.006 CHEMBL3527579 0.077 0.009 CHEMBL3527578 | ||
| 0.156 | 0.038 | 0.193 | Protein kinase (CK2) alpha inhibitor | 0.133 0.053 CHEMBL3527500 0.193 0.026 CHEMBL3527579 0.133 0.053 CHEMBL3527578 | CHEMBL3527579 | |
| 0.169 | 0.052 | 0.169 | GABA C receptor rho-2 antagonist | |||
| 0.132 | 0.016 | 0.132 | Prostaglandin-E synthase inhibitor | 0.096 0.029 CHEMBL3527500 0.083 0.037 CHEMBL3527579 0.096 0.029 CHEMBL3527578 | ||
| 0.129 | 0.014 | 0.342 | Potassium channel large-conductance Ca-activated activator | 0.342 0.004 CHEMBL3527500 0.136 0.013 CHEMBL3527579 0.342 0.004 CHEMBL3527578 0.073 0.041 CHEMBL3526428 0.073 0.041 CHEMBL3526429 | CHEMBL3527578 | |
| 0.119 | 0.004 | 0.119 | Potassium channel (ATP-sensitive) activator | 0.074 0.008 CHEMBL3527500 0.086 0.005 CHEMBL3527579 0.074 0.008 CHEMBL3527578 | ||
| 0.198 | 0.085 | 0.297 | Interleukin antagonist | 0.297 0.048 CHEMBL3527500 0.221 0.073 CHEMBL3527579 0.297 0.048 CHEMBL3527578 | CHEMBL3527578 | |
| 0.192 | 0.078 | 0.192 | I kappa B kinase epsilon inhibitor | 0.17 0.099 CHEMBL3527579 | ||
| 0.144 | 0.031 | 0.162 | CDK3/cyclin E inhibitor | 0.162 0.019 CHEMBL3527579 | CHEMBL3527579 | |
| 0.147 | 0.034 | 0.18 | Protein kinase (CK2) inhibitor | 0.141 0.037 CHEMBL3527500 0.18 0.023 CHEMBL3527579 0.141 0.037 CHEMBL3527578 | CHEMBL3527579 | |
| 0.119 | 0.006 | 0.119 | Cholecystokinin A antagonist | 0.038 0.025 CHEMBL3527579 | ||
| 0.125 | 0.013 | 0.159 | EphB4 antagonist | 0.099 0.018 CHEMBL3527500 0.159 0.01 CHEMBL3527579 0.099 0.018 CHEMBL3527578 | CHEMBL3527579 | |
| 0.115 | 0.003 | 0.242 | CXC chemokine 2 receptor antagonist | 0.242 0.002 CHEMBL3527500 0.131 0.003 CHEMBL3527579 0.242 0.002 CHEMBL3527578 | CHEMBL3527578 | |
| 0.148 | 0.037 | 0.148 | Granulocyte macrophage colony stimulating factor antagonist | 0.099 0.072 CHEMBL3527579 | ||
| 0.172 | 0.062 | 0.174 | Arachidonic acid antagonist | 0.156 0.081 CHEMBL3527500 0.174 0.061 CHEMBL3527579 0.156 0.081 CHEMBL3527578 | CHEMBL3527579 | |
| 0.157 | 0.048 | 0.165 | MAP kinase kinase inhibitor | 0.157 0.048 CHEMBL3527500 0.165 0.044 CHEMBL3527579 0.157 0.048 CHEMBL3527578 | CHEMBL3527579 | |
| 0.131 | 0.022 | 0.131 | Potassium channel (Voltage-sensitive) activator | 0.084 0.08 CHEMBL3527579 | ||
| 0.138 | 0.029 | 0.138 | Catalase inhibitor | 0.072 0.053 CHEMBL3527500 0.073 0.052 CHEMBL3527579 0.072 0.053 CHEMBL3527578 | ||
| 0.13 | 0.022 | 0.13 | Lanosterol 14 alpha demethylase inhibitor | 0.119 0.032 CHEMBL3526639 0.085 0.081 CHEMBL3527500 0.085 0.081 CHEMBL3527578 0.119 0.032 CHEMBL3526638 | ||
| 0.124 | 0.016 | 0.145 | CXC chemokine receptor antagonist | 0.145 0.011 CHEMBL3527500 0.063 0.061 CHEMBL3527579 0.145 0.011 CHEMBL3527578 | CHEMBL3527578 | |
| 0.112 | 0.004 | 0.151 | Purinergic P2X4 antagonist | 0.151 0.004 CHEMBL3527500 0.093 0.005 CHEMBL3527579 0.151 0.004 CHEMBL3527578 | CHEMBL3527578 | |
| 0.144 | 0.036 | 0.144 | GABA C receptor agonist | 0.106 0.061 CHEMBL3527500 0.121 0.049 CHEMBL3527579 0.106 0.061 CHEMBL3527578 | ||
| 0.135 | 0.027 | 0.138 | Epidermal growth factor antagonist | 0.114 0.036 CHEMBL3527500 0.138 0.026 CHEMBL3527579 0.114 0.036 CHEMBL3527578 | CHEMBL3527579 | |
| 0.154 | 0.046 | 0.328 | Interleukin 4 antagonist | 0.328 0.007 CHEMBL3527500 0.24 0.014 CHEMBL3527579 0.328 0.007 CHEMBL3527578 0.178 0.031 CHEMBL3526428 0.18 0.03 CHEMBL3527115 0.178 0.031 CHEMBL3526429 | CHEMBL3527578 | |
| 0.138 | 0.031 | 0.485 | Beta glucuronidase inhibitor | 0.331 0.005 CHEMBL3526639 0.133 0.035 CHEMBL3527500 0.138 0.031 CHEMBL3527579 0.133 0.035 CHEMBL3527578 0.331 0.005 CHEMBL3526638 0.485 0.004 CHEMBL3526428 0.408 0.004 CHEMBL3527115 0.485 0.004 CHEMBL3526429 | CHEMBL3526429 | |
| 0.132 | 0.026 | 0.132 | ErbB-4 antagonist | 0.097 0.042 CHEMBL3527500 0.104 0.038 CHEMBL3527579 0.097 0.042 CHEMBL3527578 | ||
| 0.128 | 0.024 | 0.254 | Histidine decarboxylase inhibitor | 0.163 0.017 CHEMBL3527500 0.254 0.009 CHEMBL3527579 0.163 0.017 CHEMBL3527578 | CHEMBL3527579 | |
| 0.144 | 0.04 | 0.144 | Polo-like kinase-4 inhibitor | |||
| 0.214 | 0.11 | 0.214 | 5 Hydroxytryptamine release stimulant | |||
| 0.214 | 0.112 | 0.216 | Tyrosine 3 hydroxylase inhibitor | 0.201 0.133 CHEMBL3527500 0.216 0.109 CHEMBL3527579 0.201 0.133 CHEMBL3527578 | CHEMBL3527579 | |
| 0.127 | 0.024 | 0.127 | Glutamate (mGluR7) agonist | 0.107 0.047 CHEMBL3527579 | ||
| 0.127 | 0.024 | 0.127 | p38 MAP kinase inhibitor | |||
| 0.108 | 0.005 | 0.108 | Cholecystokinin B antagonist | 0.027 0.025 CHEMBL3527500 0.033 0.019 CHEMBL3527579 0.027 0.025 CHEMBL3527578 | ||
| 0.161 | 0.059 | 0.161 | Tyrosine-protein kinase receptor antagonist | |||
| 0.147 | 0.046 | 0.147 | Platelet activating factor antagonist | 0.091 0.087 CHEMBL3527579 | ||
| 0.106 | 0.005 | 0.124 | Inosine monophosphate dehydrogenase inhibitor | 0.072 0.008 CHEMBL3527500 0.124 0.004 CHEMBL3527579 0.072 0.008 CHEMBL3527578 0.035 0.027 CHEMBL3527115 | CHEMBL3527579 | |
| 0.124 | 0.024 | 0.124 | I kappa B kinase inhibitor | 0.094 0.044 CHEMBL3527500 0.113 0.03 CHEMBL3527579 0.094 0.044 CHEMBL3527578 | ||
| 0.208 | 0.109 | 0.251 | DNA damaging | 0.176 0.139 CHEMBL3527500 0.16 0.157 CHEMBL3527579 0.176 0.139 CHEMBL3527578 0.251 0.08 CHEMBL3526428 0.214 0.105 CHEMBL3527115 0.251 0.08 CHEMBL3526429 | CHEMBL3526429 | |
| 0.165 | 0.065 | 0.295 | Diuretic | 0.178 0.055 CHEMBL3526639 0.14 0.086 CHEMBL3527500 0.124 0.1 CHEMBL3527579 0.14 0.086 CHEMBL3527578 0.178 0.055 CHEMBL3526638 0.295 0.023 CHEMBL3526428 0.271 0.027 CHEMBL3527115 0.295 0.023 CHEMBL3526429 | CHEMBL3526429 | |
| 0.118 | 0.019 | 0.118 | mTOR complex 2 inhibitor | 0.087 0.052 CHEMBL3527500 0.092 0.043 CHEMBL3527579 0.087 0.052 CHEMBL3527578 | ||
| 0.206 | 0.108 | 0.206 | Calpain inhibitor | 0.163 0.158 CHEMBL3527500 0.167 0.153 CHEMBL3527579 0.163 0.158 CHEMBL3527578 | ||
| 0.159 | 0.061 | 0.161 | CF transmembrane conductance regulator agonist | 0.133 0.111 CHEMBL3527500 0.161 0.059 CHEMBL3527579 0.133 0.111 CHEMBL3527578 | CHEMBL3527579 | |
| 0.104 | 0.007 | 0.104 | Diacylglycerol O-acyltransferase inhibitor | 0.069 0.02 CHEMBL3527500 0.061 0.025 CHEMBL3527579 0.069 0.02 CHEMBL3527578 | ||
| 0.118 | 0.022 | 0.13 | Carbonic anhydrase V inhibitor | 0.075 0.039 CHEMBL3527500 0.13 0.019 CHEMBL3527579 0.075 0.039 CHEMBL3527578 | CHEMBL3527579 | |
| 0.147 | 0.051 | 0.147 | Ca2+-transporting ATPase inhibitor | 0.138 0.079 CHEMBL3527500 0.138 0.08 CHEMBL3527579 0.138 0.079 CHEMBL3527578 0.134 0.099 CHEMBL3526428 0.134 0.1 CHEMBL3527115 0.134 0.099 CHEMBL3526429 | ||
| 0.114 | 0.02 | 0.114 | Carbonic anhydrase VA inhibitor | 0.08 0.036 CHEMBL3527500 0.079 0.037 CHEMBL3527579 0.08 0.036 CHEMBL3527578 | ||
| 0.153 | 0.062 | 0.184 | Mannose-6-phosphate isomerase inhibitor | 0.138 0.077 CHEMBL3527500 0.174 0.046 CHEMBL3527579 0.138 0.077 CHEMBL3527578 0.147 0.067 CHEMBL3526428 0.184 0.04 CHEMBL3527115 0.147 0.067 CHEMBL3526429 | CHEMBL3527115 | |
| 0.109 | 0.018 | 0.17 | Carbonic anhydrase XII inhibitor | 0.126 0.016 CHEMBL3526639 0.109 0.018 CHEMBL3527500 0.065 0.031 CHEMBL3527579 0.109 0.018 CHEMBL3527578 0.126 0.016 CHEMBL3526638 0.17 0.01 CHEMBL3526428 0.133 0.015 CHEMBL3527115 0.17 0.01 CHEMBL3526429 | CHEMBL3526429 | |
| 0.124 | 0.034 | 0.124 | NMDA receptor antagonist | 0.113 0.039 CHEMBL3527500 0.1 0.047 CHEMBL3527579 0.113 0.039 CHEMBL3527578 | ||
| 0.183 | 0.094 | 0.183 | Neurotrophic factor enhancer | 0.164 0.118 CHEMBL3527500 0.16 0.123 CHEMBL3527579 0.164 0.118 CHEMBL3527578 0.178 0.101 CHEMBL3526428 0.174 0.105 CHEMBL3527115 0.178 0.101 CHEMBL3526429 | ||
| 0.142 | 0.053 | 0.142 | Cathepsin H inhibitor | |||
| 0.143 | 0.054 | 0.27 | Cyclooxygenase 3 inhibitor | 0.14 0.058 CHEMBL3526639 0.104 0.097 CHEMBL3527500 0.104 0.097 CHEMBL3527578 0.14 0.058 CHEMBL3526638 0.27 0.007 CHEMBL3526428 0.265 0.008 CHEMBL3527115 0.27 0.007 CHEMBL3526429 | CHEMBL3526429 | |
| 0.101 | 0.014 | 0.123 | Beta 3 adrenoreceptor antagonist | 0.123 0.009 CHEMBL3527500 0.102 0.014 CHEMBL3527579 0.123 0.009 CHEMBL3527578 | CHEMBL3527578 | |
| 0.141 | 0.054 | 0.141 | TRKA antagonist | |||
| 0.092 | 0.006 | 0.18 | CXC chemokine 1 receptor antagonist | 0.18 0.004 CHEMBL3527500 0.093 0.006 CHEMBL3527579 0.18 0.004 CHEMBL3527578 | CHEMBL3527578 | |
| 0.103 | 0.017 | 0.132 | Carbonic anhydrase I inhibitor | 0.132 0.012 CHEMBL3526639 0.097 0.019 CHEMBL3527500 0.066 0.031 CHEMBL3527579 0.097 0.019 CHEMBL3527578 0.132 0.012 CHEMBL3526638 0.071 0.029 CHEMBL3526428 0.061 0.034 CHEMBL3527115 0.071 0.029 CHEMBL3526429 | CHEMBL3526638 | |
| 0.105 | 0.019 | 0.107 | Carbonic anhydrase IX inhibitor | 0.105 0.019 CHEMBL3526639 0.096 0.021 CHEMBL3527500 0.061 0.037 CHEMBL3527579 0.096 0.021 CHEMBL3527578 0.105 0.019 CHEMBL3526638 0.107 0.018 CHEMBL3526428 0.084 0.025 CHEMBL3527115 0.107 0.018 CHEMBL3526429 | CHEMBL3526429 | |
| 0.263 | 0.178 | 0.276 | Transcription factor inhibitor | 0.276 0.169 CHEMBL3527500 0.231 0.201 CHEMBL3527579 0.276 0.169 CHEMBL3527578 | CHEMBL3527578 | |
| 0.09 | 0.005 | 0.502 | Heparanase inhibitor | 0.165 0.003 CHEMBL3526639 0.088 0.005 CHEMBL3527500 0.081 0.006 CHEMBL3527579 0.088 0.005 CHEMBL3527578 0.165 0.003 CHEMBL3526638 0.502 0.001 CHEMBL3526428 0.398 0.001 CHEMBL3527115 0.502 0.001 CHEMBL3526429 | CHEMBL3526429 | |
| 0.146 | 0.062 | 0.179 | Alkaline phosphatase inhibitor | 0.179 0.043 CHEMBL3527500 0.144 0.064 CHEMBL3527579 0.179 0.043 CHEMBL3527578 0.165 0.051 CHEMBL3526428 0.168 0.049 CHEMBL3527115 0.165 0.051 CHEMBL3526429 | CHEMBL3527578 | |
| 0.241 | 0.157 | 0.241 | Calcium channel activator | |||
| 0.146 | 0.063 | 0.2 | RET inhibitor | 0.2 0.042 CHEMBL3527579 | CHEMBL3527579 | |
| 0.093 | 0.01 | 0.093 | Cyclin D1 inhibitor | 0.075 0.023 CHEMBL3527500 0.072 0.026 CHEMBL3527579 0.075 0.023 CHEMBL3527578 | ||
| 0.125 | 0.043 | 0.125 | Carbonic anhydrase XV inhibitor | 0.1 0.067 CHEMBL3527500 0.105 0.06 CHEMBL3527579 0.1 0.067 CHEMBL3527578 | ||
| 0.141 | 0.059 | 0.141 | Toll-Like receptor 2 antagonist | 0.132 0.066 CHEMBL3527500 0.138 0.061 CHEMBL3527579 0.132 0.066 CHEMBL3527578 | ||
| 0.089 | 0.007 | 0.089 | CC chemokine receptor 2B antagonist | 0.049 0.033 CHEMBL3527500 0.056 0.022 CHEMBL3527579 0.049 0.033 CHEMBL3527578 | ||
| 0.11 | 0.028 | 0.11 | Protein kinase B gamma inhibitor | |||
| 0.11 | 0.03 | 0.11 | Glutamate release inhibitor | 0.093 0.054 CHEMBL3527579 0.089 0.065 CHEMBL3526428 0.105 0.036 CHEMBL3527115 0.089 0.065 CHEMBL3526429 | ||
| 0.101 | 0.021 | 0.101 | Sphingosine 1-phosphate receptor antagonist | 0.079 0.047 CHEMBL3527500 0.1 0.021 CHEMBL3527579 0.079 0.047 CHEMBL3527578 | ||
| 0.261 | 0.181 | 0.679 | Alpha-glucosidase inhibitor | 0.312 0.154 CHEMBL3526639 0.401 0.114 CHEMBL3527500 0.293 0.163 CHEMBL3527579 0.401 0.114 CHEMBL3527578 0.312 0.154 CHEMBL3526638 0.679 0.038 CHEMBL3526428 0.618 0.05 CHEMBL3527115 0.679 0.038 CHEMBL3526429 | CHEMBL3526429 | |
| 0.089 | 0.011 | 0.089 | Purinergic P2Y antagonist | 0.045 0.031 CHEMBL3526639 0.077 0.013 CHEMBL3527500 0.06 0.019 CHEMBL3527579 0.077 0.013 CHEMBL3527578 0.045 0.031 CHEMBL3526638 0.074 0.014 CHEMBL3526428 0.04 0.037 CHEMBL3527115 0.074 0.014 CHEMBL3526429 | ||
| 0.083 | 0.005 | 0.083 | Acetyl-CoA transferase 1 inhibitor | 0.053 0.014 CHEMBL3527500 0.05 0.016 CHEMBL3527579 0.053 0.014 CHEMBL3527578 | ||
| 0.149 | 0.07 | 0.149 | Growth factor antagonist | 0.141 0.075 CHEMBL3527579 | ||
| 0.082 | 0.004 | 0.082 | Kainate receptor 5 antagonist | 0.033 0.009 CHEMBL3527500 0.034 0.008 CHEMBL3527579 0.033 0.009 CHEMBL3527578 | ||
| 0.145 | 0.068 | 0.145 | Ribosomal protein S6 kinase inhibitor | 0.127 0.084 CHEMBL3527500 0.114 0.098 CHEMBL3527579 0.127 0.084 CHEMBL3527578 | ||
| 0.103 | 0.026 | 0.146 | Carbonic anhydrase inhibitor | 0.146 0.017 CHEMBL3526639 0.097 0.028 CHEMBL3527500 0.085 0.033 CHEMBL3527579 0.097 0.028 CHEMBL3527578 0.146 0.017 CHEMBL3526638 0.079 0.035 CHEMBL3526428 0.071 0.039 CHEMBL3527115 0.079 0.035 CHEMBL3526429 | CHEMBL3526638 | |
| 0.08 | 0.004 | 0.08 | Integrin alpha2 antagonist | 0.034 0.032 CHEMBL3526639 0.048 0.012 CHEMBL3527500 0.051 0.011 CHEMBL3527579 0.048 0.012 CHEMBL3527578 0.034 0.032 CHEMBL3526638 | ||
| 0.092 | 0.016 | 0.092 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.08 | 0.004 | 0.08 | Kainate receptor 1 antagonist | 0.043 0.006 CHEMBL3527500 0.033 0.009 CHEMBL3527579 0.043 0.006 CHEMBL3527578 | ||
| 0.123 | 0.049 | 0.123 | Platelet activating factor beta antagonist | 0.089 0.071 CHEMBL3527579 | ||
| 0.079 | 0.005 | 0.079 | Potassium channel small-conductance Ca-activated activator | |||
| 0.092 | 0.018 | 0.092 | Aryl hydrocarbon receptor antagonist | 0.058 0.057 CHEMBL3527500 0.058 0.057 CHEMBL3527578 | ||
| 0.108 | 0.035 | 0.108 | Platelet growth factor antagonist | |||
| 0.093 | 0.021 | 0.122 | Carbonic anhydrase II inhibitor | 0.122 0.014 CHEMBL3526639 0.086 0.023 CHEMBL3527500 0.077 0.026 CHEMBL3527579 0.086 0.023 CHEMBL3527578 0.122 0.014 CHEMBL3526638 0.061 0.035 CHEMBL3526428 0.055 0.039 CHEMBL3527115 0.061 0.035 CHEMBL3526429 | CHEMBL3526638 | |
| 0.117 | 0.046 | 0.119 | Adenylate kinase inhibitor | 0.119 0.044 CHEMBL3526639 0.093 0.08 CHEMBL3527500 0.101 0.065 CHEMBL3527579 0.093 0.08 CHEMBL3527578 0.119 0.044 CHEMBL3526638 | CHEMBL3526638 | |
| 0.107 | 0.036 | 0.107 | Bile acid receptor antagonist | 0.106 0.037 CHEMBL3527500 0.104 0.042 CHEMBL3527579 0.106 0.037 CHEMBL3527578 | ||
| 0.08 | 0.009 | 0.08 | Antiviral (Hepatitis D) | 0.053 0.03 CHEMBL3527500 0.059 0.023 CHEMBL3527579 0.053 0.03 CHEMBL3527578 | ||
| 0.088 | 0.017 | 0.088 | I kappa B kinase 2 inhibitor | 0.072 0.03 CHEMBL3527500 0.076 0.026 CHEMBL3527579 0.072 0.03 CHEMBL3527578 | ||
| 0.085 | 0.014 | 0.085 | MDM2 inhibitor | 0.076 0.025 CHEMBL3527500 0.068 0.045 CHEMBL3527579 0.076 0.025 CHEMBL3527578 | ||
| 0.125 | 0.055 | 0.125 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.074 | 0.004 | 0.074 | Epoxide hydrolase 1 inhibitor | 0.043 0.009 CHEMBL3527500 0.043 0.009 CHEMBL3527579 0.043 0.009 CHEMBL3527578 | ||
| 0.079 | 0.009 | 0.101 | Adenine nucleotide translocase inhibitor | 0.073 0.013 CHEMBL3526639 0.101 0.004 CHEMBL3527500 0.078 0.01 CHEMBL3527579 0.101 0.004 CHEMBL3527578 0.073 0.013 CHEMBL3526638 0.1 0.004 CHEMBL3526428 0.086 0.007 CHEMBL3527115 0.1 0.004 CHEMBL3526429 | CHEMBL3527578 | |
| 0.103 | 0.034 | 0.154 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.089 0.043 CHEMBL3527500 0.154 0.013 CHEMBL3527579 0.089 0.043 CHEMBL3527578 | CHEMBL3527579 | |
| 0.257 | 0.188 | 0.308 | DNA polymerase beta inhibitor | 0.308 0.161 CHEMBL3527500 0.227 0.206 CHEMBL3527579 0.308 0.161 CHEMBL3527578 | CHEMBL3527578 | |
| 0.082 | 0.014 | 0.092 | Glucosylceramidase inhibitor | 0.092 0.01 CHEMBL3526639 0.084 0.014 CHEMBL3527500 0.064 0.027 CHEMBL3527579 0.084 0.014 CHEMBL3527578 0.092 0.01 CHEMBL3526638 0.05 0.047 CHEMBL3526428 0.05 0.047 CHEMBL3526429 | CHEMBL3526638 | |
| 0.139 | 0.072 | 0.145 | Lck kinase inhibitor | 0.145 0.068 CHEMBL3527579 | CHEMBL3527579 | |
| 0.103 | 0.037 | 0.103 | Bromodomain-containing protein 2 inhibitor | |||
| 0.112 | 0.047 | 0.112 | Hedgehog signaling inhibitor | |||
| 0.101 | 0.036 | 0.101 | Glutathione S-transferase inhibitor | 0.092 0.045 CHEMBL3527500 0.076 0.069 CHEMBL3527579 0.092 0.045 CHEMBL3527578 | ||
| 0.083 | 0.019 | 0.083 | NMDA 2A receptor antagonist | 0.073 0.023 CHEMBL3527500 0.06 0.03 CHEMBL3527579 0.073 0.023 CHEMBL3527578 | ||
| 0.09 | 0.026 | 0.09 | Vanilloid 4 agonist | |||
| 0.082 | 0.018 | 0.082 | CC chemokine 2 receptor antagonist | 0.053 0.04 CHEMBL3527579 | ||
| 0.116 | 0.052 | 0.116 | Check point kinase 2 inhibitor | 0.095 0.07 CHEMBL3527579 | ||
| 0.125 | 0.061 | 0.125 | Aurora-B kinase inhibitor | |||
| 0.083 | 0.019 | 0.083 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.064 0.029 CHEMBL3527579 | ||
| 0.094 | 0.031 | 0.094 | Lipase inhibitor | 0.073 0.051 CHEMBL3527579 | ||
| 0.146 | 0.086 | 0.24 | Src kinase inhibitor | 0.24 0.038 CHEMBL3527579 | CHEMBL3527579 | |
| 0.07 | 0.01 | 0.07 | CC chemokine 4 receptor antagonist | |||
| 0.097 | 0.037 | 0.097 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.09 0.042 CHEMBL3527500 0.089 0.043 CHEMBL3527579 0.09 0.042 CHEMBL3527578 | ||
| 0.103 | 0.043 | 0.103 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.145 | 0.085 | 0.28 | Interferon gamma antagonist | 0.131 0.11 CHEMBL3526639 0.147 0.082 CHEMBL3527500 0.14 0.093 CHEMBL3527579 0.147 0.082 CHEMBL3527578 0.131 0.11 CHEMBL3526638 0.28 0.023 CHEMBL3526428 0.263 0.026 CHEMBL3527115 0.28 0.023 CHEMBL3526429 | CHEMBL3526429 | |
| 0.063 | 0.004 | 0.063 | Integrin alpha2beta1 antagonist | 0.026 0.019 CHEMBL3526639 0.035 0.008 CHEMBL3527500 0.037 0.007 CHEMBL3527579 0.035 0.008 CHEMBL3527578 0.026 0.019 CHEMBL3526638 | ||
| 0.137 | 0.078 | 0.137 | Protein kinase (CK1) inhibitor | |||
| 0.082 | 0.024 | 0.103 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.103 0.016 CHEMBL3527500 0.096 0.018 CHEMBL3527579 0.103 0.016 CHEMBL3527578 0.068 0.032 CHEMBL3526428 0.089 0.021 CHEMBL3527115 0.068 0.032 CHEMBL3526429 | CHEMBL3527578 | |
| 0.083 | 0.025 | 0.083 | Potassium channel (ATP-sensitive) blocker | 0.069 0.042 CHEMBL3527500 0.069 0.042 CHEMBL3527578 | ||
| 0.07 | 0.012 | 0.07 | Fructose-1,6-bisphosphatase inhibitor | 0.048 0.027 CHEMBL3527500 0.046 0.029 CHEMBL3527579 0.048 0.027 CHEMBL3527578 | ||
| 0.065 | 0.007 | 0.086 | Glucagon receptor antagonist | 0.075 0.005 CHEMBL3527500 0.086 0.005 CHEMBL3527579 0.075 0.005 CHEMBL3527578 | CHEMBL3527579 | |
| 0.132 | 0.075 | 0.132 | Death-associated protein kinase 1 inhibitor | 0.124 0.099 CHEMBL3527500 0.131 0.078 CHEMBL3527579 0.124 0.099 CHEMBL3527578 | ||
| 0.076 | 0.019 | 0.077 | Dihydroorotate dehydrogenase inhibitor | 0.077 0.019 CHEMBL3527500 0.051 0.036 CHEMBL3527579 0.077 0.019 CHEMBL3527578 | CHEMBL3527578 | |
| 0.087 | 0.032 | 0.087 | Amidase inhibitor | |||
| 0.138 | 0.083 | 0.138 | Heat shock protein 70 antagonist | 0.133 0.104 CHEMBL3526428 0.134 0.102 CHEMBL3527115 0.133 0.104 CHEMBL3526429 | ||
| 0.117 | 0.062 | 0.117 | TRPA1 agonist | |||
| 0.07 | 0.016 | 0.084 | NMDA receptor subunit 3B antagonist | 0.067 0.017 CHEMBL3527500 0.084 0.013 CHEMBL3527579 0.067 0.017 CHEMBL3527578 | CHEMBL3527579 | |
| 0.088 | 0.034 | 0.088 | Cyclin B3 inhibitor | 0.088 0.034 CHEMBL3527579 | ||
| 0.055 | 0.002 | 0.055 | Thromboxane A2 agonist | 0.02 0.006 CHEMBL3526639 0.038 0.003 CHEMBL3527500 0.037 0.003 CHEMBL3527579 0.038 0.003 CHEMBL3527578 0.02 0.006 CHEMBL3526638 | ||
| 0.063 | 0.011 | 0.063 | Kainate receptor 2 antagonist | 0.033 0.028 CHEMBL3527500 0.033 0.028 CHEMBL3527578 | ||
| 0.164 | 0.112 | 0.164 | Platelet aggregation inhibitor | |||
| 0.204 | 0.152 | 0.204 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.074 | 0.022 | 0.074 | Botulinum neurotoxin type A inhibitor | 0.072 0.023 CHEMBL3527500 0.064 0.033 CHEMBL3527579 0.072 0.023 CHEMBL3527578 | ||
| 0.092 | 0.04 | 0.092 | MAP kinase 11 inhibitor | |||
| 0.082 | 0.031 | 0.082 | Phospholipase D inhibitor | |||
| 0.08 | 0.029 | 0.08 | Carbamoyl phosphate synthetase inhibitor | 0.06 0.043 CHEMBL3526639 0.058 0.045 CHEMBL3527500 0.066 0.038 CHEMBL3527579 0.058 0.045 CHEMBL3527578 0.06 0.043 CHEMBL3526638 | ||
| 0.171 | 0.12 | 0.23 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.23 0.085 CHEMBL3527500 0.201 0.099 CHEMBL3527579 0.23 0.085 CHEMBL3527578 | CHEMBL3527578 | |
| 0.078 | 0.029 | 0.078 | Exportin-1 inhibitor | |||
| 0.054 | 0.005 | 0.054 | Calcium-sensing receptor agonist | 0.033 0.011 CHEMBL3527500 0.031 0.012 CHEMBL3527579 0.033 0.011 CHEMBL3527578 | ||
| 0.084 | 0.036 | 0.084 | Check point kinase 1 inhibitor | 0.076 0.041 CHEMBL3527500 0.081 0.038 CHEMBL3527579 0.076 0.041 CHEMBL3527578 | ||
| 0.09 | 0.043 | 0.114 | Glycine receptor antagonist | 0.114 0.022 CHEMBL3526639 0.114 0.022 CHEMBL3526638 0.098 0.034 CHEMBL3526428 0.094 0.038 CHEMBL3527115 0.098 0.034 CHEMBL3526429 | CHEMBL3526638 | |
| 0.149 | 0.103 | 0.149 | Neurotensin receptor agonist | 0.14 0.128 CHEMBL3527579 | ||
| 0.076 | 0.029 | 0.076 | Glutamate (mGluR6) antagonist | 0.062 0.06 CHEMBL3527579 | ||
| 0.11 | 0.064 | 0.11 | GABA C receptor antagonist | |||
| 0.088 | 0.042 | 0.113 | ErbB-2 antagonist | 0.113 0.03 CHEMBL3527579 | CHEMBL3527579 | |
| 0.07 | 0.023 | 0.07 | Cannabinoid CB2 receptor antagonist | |||
| 0.072 | 0.026 | 0.102 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.087 0.015 CHEMBL3527500 0.102 0.01 CHEMBL3527579 0.087 0.015 CHEMBL3527578 | CHEMBL3527579 | |
| 0.055 | 0.01 | 0.072 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.056 0.009 CHEMBL3527500 0.072 0.004 CHEMBL3527579 0.056 0.009 CHEMBL3527578 | CHEMBL3527579 | |
| 0.061 | 0.016 | 0.061 | Dihydroorotase inhibitor | 0.04 0.039 CHEMBL3527579 | ||
| 0.055 | 0.01 | 0.055 | DNA gyrase subunit B inhibitor | 0.037 0.028 CHEMBL3527500 0.037 0.028 CHEMBL3527579 0.037 0.028 CHEMBL3527578 0.035 0.032 CHEMBL3526428 0.045 0.018 CHEMBL3527115 0.035 0.032 CHEMBL3526429 | ||
| 0.061 | 0.016 | 0.061 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.063 | 0.019 | 0.063 | Immunoglobulin Fc receptor antagonist | |||
| 0.061 | 0.017 | 0.083 | Glucose-6-phosphate isomerase inhibitor | 0.046 0.036 CHEMBL3526639 0.053 0.026 CHEMBL3527500 0.057 0.021 CHEMBL3527579 0.053 0.026 CHEMBL3527578 0.046 0.036 CHEMBL3526638 0.077 0.009 CHEMBL3526428 0.083 0.008 CHEMBL3527115 0.077 0.009 CHEMBL3526429 | CHEMBL3527115 | |
| 0.102 | 0.058 | 0.102 | Insulin receptor antagonist | |||
| 0.102 | 0.059 | 0.102 | GABA C receptor rho-1 antagonist | |||
| 0.05 | 0.007 | 0.05 | Protein kinase (CK2) beta inhibitor | 0.049 0.008 CHEMBL3527500 0.036 0.017 CHEMBL3527579 0.049 0.008 CHEMBL3527578 | ||
| 0.064 | 0.021 | 0.064 | Adenosine A2b receptor antagonist | |||
| 0.055 | 0.013 | 0.055 | Potassium channel KCNQ activator | |||
| 0.055 | 0.013 | 0.055 | Delayed rectifier potassium channel activator | |||
| 0.2 | 0.157 | 0.203 | Insulysin inhibitor | 0.203 0.152 CHEMBL3527579 | CHEMBL3527579 | |
| 0.084 | 0.042 | 0.084 | Rho-associated kinase II inhibitor | |||
| 0.048 | 0.007 | 0.051 | CC chemokine 1 receptor antagonist | 0.051 0.007 CHEMBL3527500 0.05 0.007 CHEMBL3527579 0.051 0.007 CHEMBL3527578 | CHEMBL3527578 | |
| 0.06 | 0.019 | 0.072 | Carbonic anhydrase VII inhibitor | 0.072 0.015 CHEMBL3527500 0.061 0.018 CHEMBL3527579 0.072 0.015 CHEMBL3527578 | CHEMBL3527578 | |
| 0.052 | 0.012 | 0.052 | Glucagon-like peptide 1 receptor antagonist | 0.037 0.034 CHEMBL3527500 0.037 0.035 CHEMBL3527579 0.037 0.034 CHEMBL3527578 | ||
| 0.149 | 0.109 | 0.149 | Death-associated protein kinase 2 inhibitor | |||
| 0.043 | 0.004 | 0.043 | Purinergic P2Y1 antagonist | 0.035 0.005 CHEMBL3527500 0.029 0.005 CHEMBL3527579 0.035 0.005 CHEMBL3527578 0.016 0.011 CHEMBL3526428 0.016 0.011 CHEMBL3526429 | ||
| 0.063 | 0.024 | 0.063 | Sphingosine 1-phosphate receptor 1 antagonist | 0.055 0.039 CHEMBL3527579 | ||
| 0.069 | 0.03 | 0.074 | Alcohol oxidase inhibitor | 0.06 0.035 CHEMBL3527500 0.074 0.027 CHEMBL3527579 0.06 0.035 CHEMBL3527578 | CHEMBL3527579 | |
| 0.087 | 0.049 | 0.087 | Carbonic anhydrase VI inhibitor | 0.073 0.068 CHEMBL3527500 0.078 0.06 CHEMBL3527579 0.073 0.068 CHEMBL3527578 | ||
| 0.099 | 0.061 | 0.114 | Creatine kinase inhibitor | 0.1 0.059 CHEMBL3527500 0.114 0.046 CHEMBL3527579 0.1 0.059 CHEMBL3527578 | CHEMBL3527579 | |
| 0.048 | 0.01 | 0.048 | Diacylglycerol O-acyltransferase 1 inhibitor | |||
| 0.077 | 0.039 | 0.077 | I kappa B kinase 1 inhibitor | 0.066 0.054 CHEMBL3527579 | ||
| 0.063 | 0.025 | 0.063 | Pregnane X receptor antagonist | 0.062 0.026 CHEMBL3527500 0.062 0.026 CHEMBL3527579 0.062 0.026 CHEMBL3527578 | ||
| 0.112 | 0.075 | 0.116 | Transcription factor STAT6 inhibitor | 0.116 0.067 CHEMBL3527579 | CHEMBL3527579 | |
| 0.068 | 0.031 | 0.068 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.115 | 0.079 | 0.239 | c-Src kinase inhibitor | 0.239 0.027 CHEMBL3527579 | CHEMBL3527579 | |
| 0.057 | 0.021 | 0.057 | Carbonic anhydrase IV inhibitor | 0.042 0.031 CHEMBL3527500 0.042 0.031 CHEMBL3527578 | ||
| 0.054 | 0.018 | 0.057 | NMDA receptor subunit 3A antagonist | 0.045 0.022 CHEMBL3527500 0.057 0.017 CHEMBL3527579 0.045 0.022 CHEMBL3527578 | CHEMBL3527579 | |
| 0.052 | 0.018 | 0.052 | Thymidine kinase inhibitor | 0.039 0.031 CHEMBL3527500 0.047 0.022 CHEMBL3527579 0.039 0.031 CHEMBL3527578 | ||
| 0.044 | 0.012 | 0.044 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.043 | 0.012 | 0.043 | CXC chemokine 3 receptor antagonist | |||
| 0.044 | 0.013 | 0.044 | Carnitine palmitoyltransferase inhibitor | |||
| 0.051 | 0.02 | 0.051 | Glutamate (mGluR4) antagonist | |||
| 0.086 | 0.057 | 0.086 | Bcr-Abl kinase inhibitor | |||
| 0.062 | 0.033 | 0.062 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.034 | 0.006 | 0.034 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.037 | 0.009 | 0.037 | MAP3K8 inhibitor | |||
| 0.111 | 0.084 | 0.111 | Glutamate receptor antagonist | |||
| 0.05 | 0.024 | 0.075 | Glutamate (mGluR group III) agonist | 0.045 0.028 CHEMBL3527500 0.075 0.014 CHEMBL3527579 0.045 0.028 CHEMBL3527578 | CHEMBL3527579 | |
| 0.051 | 0.025 | 0.051 | Adenylate cyclase 1 inhibitor | |||
| 0.056 | 0.03 | 0.056 | Aconitate hydratase inhibitor | |||
| 0.043 | 0.018 | 0.051 | CF transmembrane conductance regulator antagonist | 0.046 0.013 CHEMBL3527500 0.051 0.008 CHEMBL3527579 0.046 0.013 CHEMBL3527578 | CHEMBL3527579 | |
| 0.157 | 0.132 | 0.176 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.155 0.138 CHEMBL3527500 0.176 0.098 CHEMBL3527579 0.155 0.138 CHEMBL3527578 | CHEMBL3527579 | |
| 0.156 | 0.13 | 0.199 | Dyrk kinase inhibitor | 0.199 0.099 CHEMBL3527579 | CHEMBL3527579 | |
| 0.145 | 0.12 | 0.205 | Pyruvate kinase inhibitor | 0.205 0.078 CHEMBL3527500 0.171 0.099 CHEMBL3527579 0.205 0.078 CHEMBL3527578 | CHEMBL3527578 | |
| 0.033 | 0.008 | 0.033 | Complement factor 1r inhibitor | |||
| 0.06 | 0.036 | 0.06 | Carbonic anhydrase VB inhibitor | |||
| 0.074 | 0.05 | 0.074 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.189 | 0.165 | 0.254 | Thyroid hormone beta antagonist | 0.254 0.116 CHEMBL3527500 0.254 0.116 CHEMBL3527578 | CHEMBL3527578 | |
| 0.076 | 0.052 | 0.076 | GABA B receptor agonist | 0.074 0.055 CHEMBL3527500 0.072 0.061 CHEMBL3527579 0.074 0.055 CHEMBL3527578 | ||
| 0.039 | 0.015 | 0.039 | AMPA 1 receptor antagonist | |||
| 0.05 | 0.027 | 0.05 | Benzodiazepine antagonist | |||
| 0.074 | 0.051 | 0.074 | Potassium channel (Tandem pore domain) blocker | |||
| 0.126 | 0.103 | 0.348 | Hemostatic | 0.324 0.014 CHEMBL3526428 0.348 0.012 CHEMBL3527115 0.324 0.014 CHEMBL3526429 | CHEMBL3527115 | |
| 0.054 | 0.031 | 0.054 | Phosphodiesterase 7A inhibitor | |||
| 0.061 | 0.038 | 0.061 | Adenosine A1 receptor antagonist | |||
| 0.121 | 0.098 | 0.25 | Cell wall synthesis inhibitor | 0.114 0.109 CHEMBL3527579 0.25 0.016 CHEMBL3526428 0.239 0.018 CHEMBL3527115 0.25 0.016 CHEMBL3526429 | CHEMBL3526429 | |
| 0.03 | 0.008 | 0.03 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.023 0.016 CHEMBL3527500 0.022 0.02 CHEMBL3527579 0.023 0.016 CHEMBL3527578 | ||
| 0.074 | 0.052 | 0.074 | Rho-associated kinase I inhibitor | |||
| 0.051 | 0.03 | 0.051 | AMPA receptor antagonist | |||
| 0.061 | 0.041 | 0.061 | Alpha 2 adrenoreceptor agonist | |||
| 0.042 | 0.022 | 0.042 | 5 Hydroxytryptamine 2B agonist | |||
| 0.075 | 0.054 | 0.087 | Carbonic anhydrase XIII inhibitor | 0.07 0.058 CHEMBL3526639 0.07 0.058 CHEMBL3526638 0.077 0.052 CHEMBL3526428 0.087 0.045 CHEMBL3527115 0.077 0.052 CHEMBL3526429 | CHEMBL3527115 | |
| 0.031 | 0.011 | 0.031 | Thymidine phosphorylase inhibitor | |||
| 0.023 | 0.003 | 0.023 | Thromboxane agonist | 0.02 0.004 CHEMBL3527500 0.014 0.005 CHEMBL3527579 0.02 0.004 CHEMBL3527578 | ||
| 0.067 | 0.047 | 0.067 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.07 | 0.051 | 0.07 | NMDA 2 receptor antagonist | |||
| 0.051 | 0.032 | 0.051 | Purinergic P2X antagonist | |||
| 0.125 | 0.106 | 0.125 | Thiol protease inhibitor | |||
| 0.061 | 0.043 | 0.061 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.044 | 0.026 | 0.044 | Alpha 1L adrenoreceptor agonist | |||
| 0.049 | 0.031 | 0.049 | Cholesterol esterase inhibitor | |||
| 0.061 | 0.043 | 0.061 | NMDA 2C receptor antagonist | |||
| 0.122 | 0.104 | 0.122 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.025 | 0.007 | 0.025 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.023 0.01 CHEMBL3527579 | ||
| 0.041 | 0.024 | 0.041 | Alpha 1d adrenoreceptor agonist | |||
| 0.032 | 0.016 | 0.032 | Thrombin receptor antagonist | |||
| 0.043 | 0.027 | 0.043 | Heme oxygenase inhibitor | |||
| 0.071 | 0.055 | 0.071 | Glutamate dehydrogenase inhibitor | 0.067 0.061 CHEMBL3526639 0.067 0.061 CHEMBL3526638 | ||
| 0.023 | 0.008 | 0.023 | Alpha 2c adrenoreceptor agonist | |||
| 0.023 | 0.008 | 0.023 | Alpha 2a adrenoreceptor agonist | 0.018 0.011 CHEMBL3527579 | ||
| 0.042 | 0.027 | 0.056 | CDK5/p25 inhibitor | 0.056 0.017 CHEMBL3527579 | CHEMBL3527579 | |
| 0.035 | 0.021 | 0.035 | Glutamate (mGluR4) agonist | 0.034 0.024 CHEMBL3527500 0.034 0.024 CHEMBL3527579 0.034 0.024 CHEMBL3527578 | ||
| 0.061 | 0.047 | 0.084 | DNA gyrase inhibitor | 0.07 0.036 CHEMBL3526428 0.084 0.024 CHEMBL3527115 0.07 0.036 CHEMBL3526429 | CHEMBL3527115 | |
| 0.05 | 0.036 | 0.05 | Thromboxane A2 antagonist | |||
| 0.097 | 0.083 | 0.098 | DOPA decarboxylase inhibitor | 0.097 0.082 CHEMBL3527500 0.098 0.079 CHEMBL3527579 0.097 0.082 CHEMBL3527578 | CHEMBL3527579 | |
| 0.057 | 0.044 | 0.057 | Bombesin 1 receptor agonist | |||
| 0.028 | 0.015 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.021 CHEMBL3527579 | ||
| 0.082 | 0.069 | 0.138 | Interleukin 5 antagonist | 0.138 0.014 CHEMBL3527500 0.138 0.014 CHEMBL3527578 0.087 0.059 CHEMBL3526428 0.087 0.06 CHEMBL3527115 0.087 0.059 CHEMBL3526429 | CHEMBL3527578 | |
| 0.056 | 0.044 | 0.056 | Biliverdin reductase inhibitor | |||
| 0.186 | 0.174 | 0.257 | Thyroid hormone antagonist | 0.257 0.119 CHEMBL3527500 0.257 0.119 CHEMBL3527578 | CHEMBL3527578 | |
| 0.052 | 0.04 | 0.052 | Nicotinic alpha7 receptor agonist | |||
| 0.08 | 0.068 | 0.095 | T cell inhibitor | 0.078 0.077 CHEMBL3527579 0.095 0.029 CHEMBL3526428 0.088 0.041 CHEMBL3527115 0.095 0.029 CHEMBL3526429 | CHEMBL3526429 | |
| 0.029 | 0.017 | 0.029 | DNA polymerase III inhibitor | |||
| 0.043 | 0.031 | 0.043 | Dihydrofolate reductase inhibitor | |||
| 0.212 | 0.2 | 0.324 | 15-Lipoxygenase inhibitor | 0.324 0.115 CHEMBL3527500 0.23 0.182 CHEMBL3527579 0.324 0.115 CHEMBL3527578 | CHEMBL3527578 | |
| 0.055 | 0.044 | 0.055 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.014 | 0.003 | 0.014 | DNA topoisomerase III inhibitor | 0.009 0.004 CHEMBL3527500 0.01 0.004 CHEMBL3527579 0.009 0.004 CHEMBL3527578 | ||
| 0.034 | 0.023 | 0.034 | Factor XI inhibitor | |||
| 0.02 | 0.01 | 0.02 | Alpha 2b adrenoreceptor agonist | |||
| 0.086 | 0.076 | 0.086 | Aminopeptidase B inhibitor | |||
| 0.108 | 0.098 | 0.108 | Nav1.2 sodium channel blocker | |||
| 0.118 | 0.108 | 0.167 | Farnesoid X receptor antagonist | 0.167 0.037 CHEMBL3527500 0.125 0.094 CHEMBL3527579 0.167 0.037 CHEMBL3527578 | CHEMBL3527578 | |
| 0.208 | 0.199 | 0.269 | Antiobesity | 0.269 0.14 CHEMBL3526428 0.256 0.151 CHEMBL3527115 0.269 0.14 CHEMBL3526429 | CHEMBL3526429 | |
| 0.032 | 0.022 | 0.051 | ATP citrate lysase inhibitor | 0.046 0.009 CHEMBL3527500 0.051 0.007 CHEMBL3527579 0.046 0.009 CHEMBL3527578 | CHEMBL3527579 | |
| 0.037 | 0.028 | 0.037 | Glutamate (mGluR8) agonist | 0.036 0.03 CHEMBL3527579 | ||
| 0.036 | 0.027 | 0.036 | Bombesin 1 receptor antagonist | |||
| 0.072 | 0.062 | 0.072 | Fibroblast growth factor 3 antagonist | |||
| 0.046 | 0.038 | 0.046 | Histamine H4 receptor antagonist | |||
| 0.027 | 0.018 | 0.027 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.018 | 0.009 | 0.018 | CC chemokine 9 receptor antagonist | |||
| 0.028 | 0.02 | 0.028 | Purinergic P2Y15 antagonist | |||
| 0.053 | 0.044 | 0.053 | Potassium channel Kv1.5 blocker | |||
| 0.05 | 0.042 | 0.05 | Thromboxane antagonist | |||
| 0.019 | 0.011 | 0.019 | Potassium channel (Inward rectifier) 11 blocker | |||
| 0.021 | 0.013 | 0.021 | Factor XIII inhibitor | |||
| 0.113 | 0.105 | 0.113 | Activin receptor-like kinase 2 inhibitor | |||
| 0.087 | 0.079 | 0.087 | Carbonic anhydrase III inhibitor | |||
| 0.124 | 0.116 | 0.124 | Adenylate cyclase stimulant | |||
| 0.032 | 0.025 | 0.032 | Calcium release-activated channel blocker | |||
| 0.034 | 0.027 | 0.034 | Adenosine uptake inhibitor | |||
| 0.085 | 0.079 | 0.085 | Aurora-A kinase inhibitor | |||
| 0.052 | 0.046 | 0.052 | MAP kinase kinase 9 inhibitor | |||
| 0.051 | 0.045 | 0.062 | Beta 1 adrenoreceptor antagonist | 0.062 0.034 CHEMBL3527500 0.051 0.045 CHEMBL3527579 0.062 0.034 CHEMBL3527578 | CHEMBL3527578 | |
| 0.033 | 0.027 | 0.044 | Phosphoglycerate kinase inhibitor | 0.044 0.017 CHEMBL3527579 | CHEMBL3527579 | |
| 0.026 | 0.02 | 0.026 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.046 | 0.04 | 0.046 | Bombesin 2 receptor antagonist | |||
| 0.038 | 0.032 | 0.038 | Smo receptor antagonist | |||
| 0.05 | 0.044 | 0.05 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.028 | 0.022 | 0.028 | AMPA 3 receptor antagonist | |||
| 0.018 | 0.013 | 0.018 | Complement factor D inhibitor | |||
| 0.013 | 0.008 | 0.013 | Carbonic anhydrase XI inhibitor | |||
| 0.022 | 0.017 | 0.028 | Beta 1 adrenoreceptor agonist | 0.028 0.009 CHEMBL3527500 0.022 0.017 CHEMBL3527579 0.028 0.009 CHEMBL3527578 | CHEMBL3527578 | |
| 0.013 | 0.009 | 0.013 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.039 | 0.035 | 0.039 | Kainate receptor agonist | |||
| 0.044 | 0.04 | 0.044 | Aldosterone antagonist | |||
| 0.026 | 0.022 | 0.026 | Cyclin E2 inhibitor | |||
| 0.023 | 0.019 | 0.023 | Integrin alpha4 antagonist | |||
| 0.098 | 0.095 | 0.098 | Protein kinase (CK1) delta inhibitor | |||
| 0.076 | 0.074 | 0.076 | Histamine H2 receptor antagonist | |||
| 0.018 | 0.016 | 0.023 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.023 0.011 CHEMBL3527579 | CHEMBL3527579 | |
| 0.036 | 0.035 | 0.036 | Factor XIa inhibitor | |||
| 0.014 | 0.012 | 0.014 | Integrin alpha4beta1 antagonist | |||
| 0.058 | 0.057 | 0.071 | Beta 2 adrenoreceptor agonist | 0.071 0.017 CHEMBL3527500 0.069 0.022 CHEMBL3527579 0.071 0.017 CHEMBL3527578 | CHEMBL3527578 | |
| 0.034 | 0.033 | 0.034 | Delayed rectifier potassium channel blocker | |||
| 0.064 | 0.064 | 0.068 | Glutamate decarboxylase inhibitor | 0.068 0.057 CHEMBL3527579 | CHEMBL3527579 | |
| 0.081 | 0.084 | 0.104 | DNA directed RNA polymerase inhibitor | 0.104 0.053 CHEMBL3527500 0.104 0.053 CHEMBL3527578 | CHEMBL3527578 | |
| 0.043 | 0.047 | 0.06 | Beta 2 adrenoreceptor antagonist | 0.06 0.024 CHEMBL3527500 0.05 0.037 CHEMBL3527579 0.06 0.024 CHEMBL3527578 | CHEMBL3527578 | |
| 0.11 | 0.115 | 0.132 | Vanilloid 1 agonist | 0.132 0.062 CHEMBL3527579 0.112 0.108 CHEMBL3527115 | CHEMBL3527579 | |
| 0.149 | 0.155 | 0.235 | Cyclic AMP phosphodiesterase inhibitor | 0.235 0.071 CHEMBL3526639 0.235 0.071 CHEMBL3526638 0.225 0.077 CHEMBL3526428 0.232 0.073 CHEMBL3527115 0.225 0.077 CHEMBL3526429 | CHEMBL3526638 | |
| 0.168 | 0.179 | 0.238 | Lipoxygenase inhibitor | 0.238 0.108 CHEMBL3527500 0.201 0.139 CHEMBL3527579 0.238 0.108 CHEMBL3527578 | CHEMBL3527578 | |
| 0.007 | 0.02 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.009 CHEMBL3526428 0.01 0.008 CHEMBL3527115 0.01 0.009 CHEMBL3526429 | CHEMBL3526429 | |
| 0.089 | 0.103 | 0.209 | Alkylator | 0.149 0.047 CHEMBL3526639 0.149 0.047 CHEMBL3526638 0.209 0.024 CHEMBL3526428 0.184 0.031 CHEMBL3527115 0.209 0.024 CHEMBL3526429 | CHEMBL3526429 | |
| 0.053 | 0.068 | 0.077 | Beta adrenoreceptor antagonist | 0.077 0.029 CHEMBL3527500 0.063 0.049 CHEMBL3527579 0.077 0.029 CHEMBL3527578 | CHEMBL3527578 | |
| 0.02 | 0.036 | 0.026 | Thyroid hormone agonist | 0.024 0.023 CHEMBL3527500 0.026 0.018 CHEMBL3527579 0.024 0.023 CHEMBL3527578 | CHEMBL3527579 | |
| 0.09 | 0.107 | 0.331 | Amylase inhibitor | 0.291 0.019 CHEMBL3526428 0.331 0.015 CHEMBL3527115 0.291 0.019 CHEMBL3526429 | CHEMBL3527115 | |
| 0.051 | 0.068 | 0.115 | Phosphofructokinase-1 inhibitor | 0.071 0.047 CHEMBL3526639 0.071 0.047 CHEMBL3526638 0.1 0.031 CHEMBL3526428 0.115 0.027 CHEMBL3527115 0.1 0.031 CHEMBL3526429 | CHEMBL3527115 | |
| 0.04 | 0.06 | 0.049 | Beta adrenoreceptor agonist | 0.049 0.019 CHEMBL3527500 0.047 0.026 CHEMBL3527579 0.049 0.019 CHEMBL3527578 | CHEMBL3527578 | |
| 0.234 | 0.255 | 0.257 | MAP kinase 1 inhibitor | 0.257 0.225 CHEMBL3527579 | CHEMBL3527579 | |
| 0.063 | 0.085 | 0.114 | Adrenaline agonist | 0.114 0.028 CHEMBL3527500 0.093 0.043 CHEMBL3527579 0.114 0.028 CHEMBL3527578 | CHEMBL3527578 | |
| 0.086 | 0.111 | 0.102 | Beta amyloid protein antagonist | 0.102 0.087 CHEMBL3527115 | CHEMBL3527115 | |
| 0.063 | 0.088 | 0.079 | Androgen antagonist | 0.079 0.067 CHEMBL3527579 | CHEMBL3527579 | |
| 0.035 | 0.059 | 0.085 | Carbonic anhydrase XIV inhibitor | 0.085 0.015 CHEMBL3526639 0.085 0.015 CHEMBL3526638 0.046 0.038 CHEMBL3526428 0.056 0.027 CHEMBL3527115 0.046 0.038 CHEMBL3526429 | CHEMBL3526638 | |
| 0.065 | 0.091 | 0.075 | Viral attachment inhibitor | 0.075 0.061 CHEMBL3526639 0.075 0.061 CHEMBL3526638 | CHEMBL3526638 | |
| 0.127 | 0.159 | 0.177 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.177 0.108 CHEMBL3527579 | CHEMBL3527579 | |
| 0.074 | 0.106 | 0.085 | Protein kinase C zeta inhibitor | 0.085 0.076 CHEMBL3527579 | CHEMBL3527579 | |
| 0.134 | 0.167 | 0.262 | Antiamyloidogenic | 0.218 0.087 CHEMBL3527500 0.156 0.139 CHEMBL3527579 0.218 0.087 CHEMBL3527578 0.259 0.067 CHEMBL3526428 0.262 0.066 CHEMBL3527115 0.259 0.067 CHEMBL3526429 | CHEMBL3527115 | |
| 0.115 | 0.154 | 0.296 | DNA methyltransferase I inhibitor | 0.136 0.121 CHEMBL3526639 0.136 0.121 CHEMBL3526638 0.223 0.058 CHEMBL3526428 0.296 0.028 CHEMBL3527115 0.223 0.058 CHEMBL3526429 | CHEMBL3527115 | |
| 0.132 | 0.172 | 0.477 | Immunostimulant | 0.397 0.05 CHEMBL3526639 0.397 0.05 CHEMBL3526638 0.428 0.042 CHEMBL3526428 0.477 0.032 CHEMBL3527115 0.428 0.042 CHEMBL3526429 | CHEMBL3527115 | |
| 0.058 | 0.099 | 0.075 | Keratolytic | 0.075 0.057 CHEMBL3527500 0.075 0.057 CHEMBL3527578 | CHEMBL3527578 | |
| 0.106 | 0.149 | 0.203 | Dual specificity phosphatase 3 inhibitor | 0.203 0.059 CHEMBL3527500 0.163 0.086 CHEMBL3527579 0.203 0.059 CHEMBL3527578 | CHEMBL3527578 | |
| 0.013 | 0.059 | 0.035 | Arginase inhibitor | 0.032 0.029 CHEMBL3526428 0.035 0.027 CHEMBL3527115 0.032 0.029 CHEMBL3526429 | CHEMBL3527115 | |
| 0.036 | 0.081 | 0.063 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.063 0.027 CHEMBL3527579 | CHEMBL3527579 | |
| 0.073 | 0.121 | 0.123 | Adenylate cyclase inhibitor | 0.123 0.065 CHEMBL3527579 | CHEMBL3527579 | |
| 0.016 | 0.067 | 0.075 | Sodium/glucose cotransporter inhibitor | 0.032 0.01 CHEMBL3526639 0.032 0.01 CHEMBL3526638 0.075 0.004 CHEMBL3526428 0.066 0.004 CHEMBL3527115 0.075 0.004 CHEMBL3526429 | CHEMBL3526429 | |
| 0.131 | 0.184 | 0.209 | Interleukin agonist | 0.198 0.122 CHEMBL3526428 0.209 0.112 CHEMBL3527115 0.198 0.122 CHEMBL3526429 | CHEMBL3527115 | |
| 0.067 | 0.123 | 0.158 | Thioredoxin inhibitor | 0.158 0.015 CHEMBL3526428 0.131 0.024 CHEMBL3527115 0.158 0.015 CHEMBL3526429 | CHEMBL3526429 | |
| 0.159 | 0.215 | 0.506 | Transcription factor NF kappa B inhibitor | 0.215 0.155 CHEMBL3527579 0.506 0.043 CHEMBL3526428 0.495 0.045 CHEMBL3527115 0.506 0.043 CHEMBL3526429 | CHEMBL3526429 | |
| 0.012 | 0.07 | 0.084 | Sodium/glucose cotransporter 2 inhibitor | 0.027 0.017 CHEMBL3526639 0.027 0.017 CHEMBL3526638 0.084 0.004 CHEMBL3526428 0.077 0.004 CHEMBL3527115 0.084 0.004 CHEMBL3526429 | CHEMBL3526429 | |
| 0.094 | 0.155 | 0.176 | DNA repair enzyme inhibitor | 0.175 0.015 CHEMBL3526428 0.176 0.015 CHEMBL3527115 0.175 0.015 CHEMBL3526429 | CHEMBL3527115 | |
| 0.103 | 0.166 | 0.208 | Heat shock protein 90 alpha antagonist | 0.177 0.065 CHEMBL3527500 0.208 0.045 CHEMBL3527579 0.177 0.065 CHEMBL3527578 | CHEMBL3527579 | |
| 0.109 | 0.173 | 0.295 | DNA methylase inhibitor | 0.138 0.129 CHEMBL3526639 0.138 0.129 CHEMBL3526638 0.23 0.06 CHEMBL3526428 0.295 0.029 CHEMBL3527115 0.23 0.06 CHEMBL3526429 | CHEMBL3527115 | |
| 0.073 | 0.148 | 0.126 | Microtubule formation inhibitor | 0.126 0.054 CHEMBL3527115 | CHEMBL3527115 | |
| 0.005 | 0.081 | 0.016 | Ileal bile acid transport inhibitor | 0.016 0.012 CHEMBL3526639 0.016 0.012 CHEMBL3526638 0.016 0.013 CHEMBL3527115 | CHEMBL3527115 | |
| 0.035 | 0.116 | 0.057 | Dopamine D1 antagonist | 0.057 0.054 CHEMBL3527579 | CHEMBL3527579 | |
| 0.086 | 0.172 | 0.147 | Mcl-1 antagonist | 0.147 0.092 CHEMBL3527500 0.147 0.092 CHEMBL3527578 | CHEMBL3527578 | |
| 0.028 | 0.119 | 0.061 | Alpha-mannosidase inhibitor | 0.058 0.03 CHEMBL3526639 0.058 0.03 CHEMBL3526638 0.057 0.031 CHEMBL3526428 0.061 0.026 CHEMBL3527115 0.057 0.031 CHEMBL3526429 | CHEMBL3527115 | |
| 0.098 | 0.189 | 0.194 | Dual specificity phosphatase inhibitor | 0.194 0.058 CHEMBL3527500 0.163 0.081 CHEMBL3527579 0.194 0.058 CHEMBL3527578 | CHEMBL3527578 | |
| 0.057 | 0.149 | 0.122 | ATPase (Vacuolar H+) inhibitor | 0.12 0.019 CHEMBL3526428 0.122 0.018 CHEMBL3527115 0.12 0.019 CHEMBL3526429 | CHEMBL3527115 | |
| 0.02 | 0.116 | 0.054 | Mannosidase inhibitor | 0.051 0.024 CHEMBL3526639 0.051 0.024 CHEMBL3526638 0.05 0.026 CHEMBL3526428 0.054 0.021 CHEMBL3527115 0.05 0.026 CHEMBL3526429 | CHEMBL3527115 | |
| 0.035 | 0.135 | 0.08 | Na+ K+ transporting ATPase inhibitor | 0.071 0.059 CHEMBL3526428 0.08 0.051 CHEMBL3527115 0.071 0.059 CHEMBL3526429 | CHEMBL3527115 | |
| 0.102 | 0.206 | 0.299 | Hypolipemic | 0.22 0.082 CHEMBL3526639 0.22 0.082 CHEMBL3526638 0.299 0.049 CHEMBL3526428 0.299 0.049 CHEMBL3527115 0.299 0.049 CHEMBL3526429 | CHEMBL3526429 | |
| 0.078 | 0.186 | 0.138 | Protein kinase stimulant | 0.12 0.092 CHEMBL3526428 0.138 0.077 CHEMBL3527115 0.12 0.092 CHEMBL3526429 | CHEMBL3527115 | |
| 0.101 | 0.21 | 0.229 | Non-steroidal antiinflammatory agent | 0.223 0.056 CHEMBL3526428 0.229 0.052 CHEMBL3527115 0.223 0.056 CHEMBL3526429 | CHEMBL3527115 | |
| 0.106 | 0.221 | 0.151 | CC chemokine 6 receptor antagonist | 0.134 0.056 CHEMBL3526639 0.122 0.105 CHEMBL3527579 0.134 0.056 CHEMBL3526638 0.145 0.029 CHEMBL3526428 0.151 0.021 CHEMBL3527115 0.145 0.029 CHEMBL3526429 | CHEMBL3527115 | |
| 0.006 | 0.123 | 0.014 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.014 0.012 CHEMBL3526639 0.014 0.012 CHEMBL3526638 0.014 0.012 CHEMBL3526428 0.014 0.012 CHEMBL3526429 | CHEMBL3526429 | |
| 0.144 | 0.261 | 0.562 | Antithrombotic | 0.205 0.172 CHEMBL3526639 0.205 0.172 CHEMBL3526638 0.562 0.021 CHEMBL3526428 0.469 0.034 CHEMBL3527115 0.562 0.021 CHEMBL3526429 | CHEMBL3526429 | |
| 0.09 | 0.219 | 0.159 | Melanin inhibitor | 0.144 0.091 CHEMBL3526428 0.159 0.07 CHEMBL3527115 0.144 0.091 CHEMBL3526429 | CHEMBL3527115 | |
| 0.054 | 0.188 | 0.109 | Xanthine oxidase inhibitor | 0.109 0.053 CHEMBL3526428 0.1 0.06 CHEMBL3527115 0.109 0.053 CHEMBL3526429 | CHEMBL3526429 | |
| 0.033 | 0.168 | 0.066 | Heat shock protein 90 beta antagonist | 0.066 0.032 CHEMBL3527579 | CHEMBL3527579 | |
| 0.155 | 0.291 | 0.608 | Antibacterial | 0.359 0.097 CHEMBL3526639 0.359 0.097 CHEMBL3526638 0.604 0.019 CHEMBL3526428 0.608 0.018 CHEMBL3527115 0.604 0.019 CHEMBL3526429 | CHEMBL3527115 | |
| 0.027 | 0.164 | 0.09 | Factor IXa inhibitor | 0.09 0.013 CHEMBL3526639 0.09 0.013 CHEMBL3526638 0.079 0.016 CHEMBL3526428 0.087 0.014 CHEMBL3527115 0.079 0.016 CHEMBL3526429 | CHEMBL3526638 | |
| 0.146 | 0.288 | 0.27 | Caspase 3 stimulant | 0.27 0.097 CHEMBL3526428 0.264 0.101 CHEMBL3527115 0.27 0.097 CHEMBL3526429 | CHEMBL3526429 | |
| 0.151 | 0.295 | 0.401 | Interleukin 2 agonist | 0.292 0.079 CHEMBL3526639 0.292 0.079 CHEMBL3526638 0.399 0.028 CHEMBL3526428 0.401 0.027 CHEMBL3527115 0.399 0.028 CHEMBL3526429 | CHEMBL3527115 | |
| 0.129 | 0.28 | 0.284 | Vasodilator, coronary | 0.27 0.114 CHEMBL3526428 0.284 0.101 CHEMBL3527115 0.27 0.114 CHEMBL3526429 | CHEMBL3527115 | |
| 0.091 | 0.246 | 0.136 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.136 0.101 CHEMBL3527579 | CHEMBL3527579 | |
| 0.031 | 0.2 | 0.138 | Monophenol monooxygenase inhibitor | 0.138 0.052 CHEMBL3526428 0.128 0.057 CHEMBL3527115 0.138 0.052 CHEMBL3526429 | CHEMBL3526429 | |
| 0.006 | 0.179 | 0.021 | Adenosine A1 receptor agonist | 0.021 0.02 CHEMBL3526639 0.021 0.02 CHEMBL3526638 | CHEMBL3526638 | |
| 0.047 | 0.235 | 0.159 | DNA polymerase I inhibitor | 0.136 0.057 CHEMBL3526639 0.136 0.057 CHEMBL3526638 0.122 0.067 CHEMBL3526428 0.159 0.044 CHEMBL3527115 0.122 0.067 CHEMBL3526429 | CHEMBL3527115 | |
| 0.118 | 0.316 | 0.383 | Peptidyltransferase inhibitor | 0.304 0.023 CHEMBL3526639 0.304 0.023 CHEMBL3526638 0.376 0.009 CHEMBL3526428 0.383 0.008 CHEMBL3527115 0.376 0.009 CHEMBL3526429 | CHEMBL3527115 | |
| 0.063 | 0.272 | 0.148 | Heat shock protein 90 antagonist | 0.148 0.076 CHEMBL3527579 | CHEMBL3527579 | |
| 0.032 | 0.249 | 0.143 | Expectorant | 0.116 0.054 CHEMBL3526428 0.143 0.038 CHEMBL3527115 0.116 0.054 CHEMBL3526429 | CHEMBL3527115 | |
| 0.011 | 0.249 | 0.054 | Aldose reductase inhibitor | 0.054 0.036 CHEMBL3526428 0.046 0.043 CHEMBL3527115 0.054 0.036 CHEMBL3526429 | CHEMBL3526429 | |
| 0.066 | 0.319 | 0.222 | Insulin secretagoues | 0.222 0.026 CHEMBL3526428 0.218 0.028 CHEMBL3527115 0.222 0.026 CHEMBL3526429 | CHEMBL3526429 | |
| 0.062 | 0.319 | 0.362 | Platelet adhesion inhibitor | 0.192 0.076 CHEMBL3526639 0.192 0.076 CHEMBL3526638 0.362 0.017 CHEMBL3526428 0.349 0.02 CHEMBL3527115 0.362 0.017 CHEMBL3526429 | CHEMBL3526429 | |
| 0.049 | 0.327 | 0.115 | Interleukin 12 antagonist | 0.099 0.056 CHEMBL3526428 0.115 0.034 CHEMBL3527115 0.099 0.056 CHEMBL3526429 | CHEMBL3527115 | |
| 0.019 | 0.328 | 0.157 | Topoisomerase II alpha inhibitor | 0.157 0.022 CHEMBL3526428 0.122 0.029 CHEMBL3527115 0.157 0.022 CHEMBL3526429 | CHEMBL3526429 | |
| 0.054 | 0.395 | 0.644 | Tumour necrosis factor alpha release inhibitor | 0.644 0.005 CHEMBL3526639 0.644 0.005 CHEMBL3526638 0.295 0.055 CHEMBL3526428 0.307 0.051 CHEMBL3527115 0.295 0.055 CHEMBL3526429 | CHEMBL3526638 | |
| 0.052 | 0.425 | 0.23 | NOS3 expression enhancer | 0.223 0.033 CHEMBL3526428 0.23 0.031 CHEMBL3527115 0.223 0.033 CHEMBL3526429 | CHEMBL3527115 | |
| 0.006 | 0.414 | 0.059 | Protein 30S ribosomal subunit inhibitor | 0.059 0.006 CHEMBL3526428 0.046 0.009 CHEMBL3527115 0.059 0.006 CHEMBL3526429 | CHEMBL3526429 | |
| 0.028 | 0.452 | 0.208 | Anticoagulant | 0.208 0.05 CHEMBL3526428 0.19 0.057 CHEMBL3527115 0.208 0.05 CHEMBL3526429 | CHEMBL3526429 | |
| 0.015 | 0.44 | 0.073 | Glucose-6-phosphate translocase inhibitor | 0.047 0.045 CHEMBL3526639 0.047 0.045 CHEMBL3526638 0.073 0.014 CHEMBL3526428 0.072 0.015 CHEMBL3527115 0.073 0.014 CHEMBL3526429 | CHEMBL3526429 | |
| 0.01 | 0.463 | 0.07 | Neuraminidase (influenza) inhibitor | 0.067 0.04 CHEMBL3526428 0.07 0.035 CHEMBL3527115 0.067 0.04 CHEMBL3526429 | CHEMBL3527115 | |
| 0.004 | 0.468 | 0.051 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.051 0.015 CHEMBL3527579 | CHEMBL3527579 | |
| 0.058 | 0.535 | 0.433 | Immunomodulator | 0.216 0.146 CHEMBL3526639 0.216 0.146 CHEMBL3526638 0.361 0.056 CHEMBL3526428 0.433 0.035 CHEMBL3527115 0.361 0.056 CHEMBL3526429 | CHEMBL3527115 | |
| 0.006 | 0.51 | 0.063 | Neuraminidase inhibitor | 0.054 0.051 CHEMBL3526428 0.063 0.039 CHEMBL3527115 0.054 0.051 CHEMBL3526429 | CHEMBL3527115 | |
| 0.068 | 0.573 | 0.729 | Cyclophilin D inhibitor | 0.597 0.028 CHEMBL3526639 0.597 0.028 CHEMBL3526638 0.719 0.012 CHEMBL3526428 0.729 0.011 CHEMBL3527115 0.719 0.012 CHEMBL3526429 | CHEMBL3527115 | |
| 0.024 | 0.534 | 0.274 | Platelet antagonist | 0.274 0.062 CHEMBL3526428 0.216 0.091 CHEMBL3527115 0.274 0.062 CHEMBL3526429 | CHEMBL3526429 | |
| 0.006 | 0.532 | 0.342 | Selectin antagonist | 0.201 0.011 CHEMBL3526639 0.201 0.011 CHEMBL3526638 0.342 0.004 CHEMBL3526428 0.324 0.005 CHEMBL3527115 0.342 0.004 CHEMBL3526429 | CHEMBL3526429 | |
| 0.074 | 0.602 | 0.741 | Antiinflammatory | 0.616 0.049 CHEMBL3526639 0.616 0.049 CHEMBL3526638 0.741 0.024 CHEMBL3526428 0.692 0.032 CHEMBL3527115 0.741 0.024 CHEMBL3526429 | CHEMBL3526429 | |
| 0.011 | 0.543 | 0.071 | Antibiotic Aminoglycoside-like | 0.042 0.019 CHEMBL3526639 0.042 0.019 CHEMBL3526638 0.07 0.006 CHEMBL3526428 0.071 0.006 CHEMBL3527115 0.07 0.006 CHEMBL3526429 | CHEMBL3527115 | |
| 0.024 | 0.567 | 0.156 | Toll-Like receptor 4 antagonist | 0.156 0.018 CHEMBL3526428 0.144 0.025 CHEMBL3527115 0.156 0.018 CHEMBL3526429 | CHEMBL3526429 | |
| 0.06 | 0.607 | 0.356 | Apoptosis antagonist | 0.356 0.053 CHEMBL3526428 0.355 0.054 CHEMBL3527115 0.356 0.053 CHEMBL3526429 | CHEMBL3526429 | |
| 0.01 | 0.573 | 0.03 | Toll-Like receptor 4 agonist | 0.028 0.014 CHEMBL3526428 0.03 0.012 CHEMBL3527115 0.028 0.014 CHEMBL3526429 | CHEMBL3527115 | |
| 0.041 | 0.612 | 0.576 | Hypoglycemic | 0.232 0.088 CHEMBL3526639 0.232 0.088 CHEMBL3526638 0.555 0.011 CHEMBL3526428 0.576 0.009 CHEMBL3527115 0.555 0.011 CHEMBL3526429 | CHEMBL3527115 | |
| 0.009 | 0.625 | 0.181 | Topoisomerase II inhibitor | 0.181 0.038 CHEMBL3526428 0.16 0.045 CHEMBL3527115 0.181 0.038 CHEMBL3526429 | CHEMBL3526429 | |
| 0.043 | 0.67 | 0.482 | Apoptosis agonist | 0.304 0.169 CHEMBL3526639 0.304 0.169 CHEMBL3526638 0.482 0.08 CHEMBL3526428 0.474 0.082 CHEMBL3527115 0.482 0.08 CHEMBL3526429 | CHEMBL3526429 | |
| 0.027 | 0.671 | 0.137 | Transcription factor NF kappa B stimulant | 0.134 0.02 CHEMBL3526428 0.137 0.019 CHEMBL3527115 0.134 0.02 CHEMBL3526429 | CHEMBL3527115 | |
| 0.027 | 0.677 | 0.438 | Immunosuppressant | 0.267 0.136 CHEMBL3526639 0.267 0.136 CHEMBL3526638 0.415 0.057 CHEMBL3526428 0.438 0.051 CHEMBL3527115 0.415 0.057 CHEMBL3526429 | CHEMBL3527115 | |
| 0.008 | 0.699 | 0.22 | Lipid peroxidase inhibitor | 0.188 0.047 CHEMBL3526639 0.188 0.047 CHEMBL3526638 0.209 0.038 CHEMBL3526428 0.22 0.034 CHEMBL3527115 0.209 0.038 CHEMBL3526429 | CHEMBL3527115 | |
| 0.026 | 0.758 | 0.368 | Hepatoprotectant | 0.186 0.075 CHEMBL3526639 0.186 0.075 CHEMBL3526638 0.355 0.018 CHEMBL3526428 0.368 0.016 CHEMBL3527115 0.355 0.018 CHEMBL3526429 | CHEMBL3527115 | |
| 0.006 | 0.744 | 0.114 | Estrogen receptor beta antagonist | 0.114 0.04 CHEMBL3527579 | CHEMBL3527579 | |
| 0.02 | 0.779 | 0.059 | Lipocortins synthesis agonist | 0.057 0.043 CHEMBL3526428 0.059 0.038 CHEMBL3527115 0.057 0.043 CHEMBL3526429 | CHEMBL3527115 | |
| 0.009 | 0.8 | 0.266 | Thrombolytic | 0.266 0.03 CHEMBL3526428 0.243 0.035 CHEMBL3527115 0.266 0.03 CHEMBL3526429 | CHEMBL3526429 | |
| 0.007 | 0.801 | 0.443 | Free radical scavenger | 0.198 0.099 CHEMBL3526639 0.198 0.099 CHEMBL3526638 0.43 0.024 CHEMBL3526428 0.443 0.023 CHEMBL3527115 0.43 0.024 CHEMBL3526429 | CHEMBL3527115 | |
| 0.006 | 0.828 | 0.487 | Antioxidant | 0.24 0.089 CHEMBL3526639 0.24 0.089 CHEMBL3526638 0.476 0.023 CHEMBL3526428 0.487 0.021 CHEMBL3527115 0.476 0.023 CHEMBL3526429 | CHEMBL3527115 | |
| 0.007 | 0.846 | 0.316 | Nitric oxide antagonist | 0.296 0.041 CHEMBL3526428 0.316 0.037 CHEMBL3527115 0.296 0.041 CHEMBL3526429 | CHEMBL3527115 | |
| 0.005 | 0.857 | 0.135 | Topoisomerase I inhibitor | 0.135 0.048 CHEMBL3526428 0.124 0.053 CHEMBL3527115 0.135 0.048 CHEMBL3526429 | CHEMBL3526429 | |
| 0.005 | 0.867 | 0.114 | Estrogen antagonist | 0.114 0.066 CHEMBL3527579 | CHEMBL3527579 | |
| 0.007 | 0.874 | 0.183 | Vasodilator | 0.162 0.14 CHEMBL3526428 0.183 0.119 CHEMBL3527115 0.162 0.14 CHEMBL3526429 | CHEMBL3527115 | |
| 0.003 | 0.892 | 0.13 | Antineoplastic antibiotic | 0.125 0.037 CHEMBL3526428 0.13 0.036 CHEMBL3527115 0.125 0.037 CHEMBL3526429 | CHEMBL3527115 | |
| 0.006 | 0.945 | 0.566 | Angiogenesis stimulant | 0.301 0.049 CHEMBL3526639 0.301 0.049 CHEMBL3526638 0.564 0.008 CHEMBL3526428 0.566 0.008 CHEMBL3527115 0.564 0.008 CHEMBL3526429 | CHEMBL3527115 | |
| 0.004 | 0.947 | 0.087 | Protein 50S ribosomal subunit inhibitor | 0.085 0.018 CHEMBL3526428 0.087 0.017 CHEMBL3527115 0.085 0.018 CHEMBL3526429 | CHEMBL3527115 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |